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ABSTRACT 
Humans are synchronized to the 24-hour day by the light-dark cycle of the environment. 
Through alteration of the suprachiasmatic nucleus (SCN), the brain’s circadian pacemaker, 
exposure to light at night (LAN) influences the functions in the body that operate with circadian 
regularity, including the endocrine, immune and digestive systems.[1] The SCN also signals to 
the pineal gland to modulate production of melatonin, a hormone that has established antimitotic 
and antiproliferative properties, and has been shown to regulate estrogen and other hormones 
important in breast cancer etiology.[1-3]  
 People who work occupational night shifts are exposed to LAN and thereby experience 
circadian disruption, including delayed melatonin onset and reduction in peak nightly 
production.[4-6] In 2007, the International Agency for Research on Cancer (IARC) at the World 
Health Organization (WHO) declared shift work that involves circadian disruption to be 
“probably carcinogenic to humans” (group 2A).[7] The IARC working group cited strong 
experimental evidence from animals and supportive but limited human evidence from 
epidemiologic studies. 
This dissertation investigates several relationships on the pathway from rotating night 
shift work exposure to breast cancer, through mammographic breast density. Mammographic 
density, or the proportion of fibroglandular tissue in a woman’s breast as viewed on a 
mammogram, is the strongest risk factor for breast cancer, and has been reported as associated 
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with a 4-6 fold increased risk of breast cancer.[8-10] It is therefore, a reasonable intermediate 
endpoint for breast cancer. 
The analyses in this dissertation use data from two large longitudinal cohorts of female 
registered nurses in the United States, the Nurse’s Health Study and Nurse’s Health Study II, and 
are presented in a series of three papers. In the first paper, the prospective and long-term 
association of rotating night shift work and breast cancer is assessed with 24 years of follow-up, 
allowing for some analysis of the timing of exposure and tumor subtypes. In the second paper, 
the prospective relationship of rotating night shift work and mammographic density, as measured 
from screening mammograms, is evaluated. In the third paper, first morning void urinary 6-
sulfatoxymelatonin, the main metabolite of melatonin excreted in urine, serves as a biomarker of 
circadian disruption, and is evaluated in relation to mammographic density in a cross-sectional 
analysis.  
Overall, this dissertation work provides evidence in favor of an association between long-
term rotating night shift work and breast cancer, and suggests that long durations of shift work 
early in a nurse’s career may be of particular importance. Such shift work may occur in a time 
period, between puberty and breast involution due to childbirth or aging, during which breast 
tissue is vulnerable to carcinogenic influences. Rotating night shift work and a single measure of 
urinary melatonin did not appear to be related to mammographic breast density, suggesting that 
if rotating night shift work raises a woman’s risk of breast cancer, it is unlikely to do so through 
influence on mammographic density. 
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ABSTRACT 
Background. In 2007, the International Agency for Research on Cancer (IARC) declared shift 
work to be probably carcinogenic to humans, citing earlier results from the Nurses’ Health Study 
(NHS and NHS2) cohorts. We updated these findings with twice the follow-up time. 
Methods. We prospectively evaluated the association between rotating night shift work and 
breast cancer risk among 78,516 NHS and 114,559 NHS2 participants using Cox proportional 
hazards models. All statistical tests were two-sided. 
Results. Over 24 years of follow-up, 9,541 incident invasive breast malignancies occurred. 
Compared to women who never worked rotating night shifts, women in NHS with 30+ years of 
rotating night shift work at baseline had no increased risk of breast cancer (HR=0.95, 95%CI 
0.77-1.17; Ptrend=0.63). In NHS2, breast cancer risk was significantly increased for women with 
20+ years of rotating night shift work at baseline (HR=2.15, 95%CI 1.23-3.73; Ptrend=0.23) and 
marginally increased for women with 20+ years of cumulative rotating night shift work (using 
updated exposure information) (HR =1.40, 95%CI 1.00-1.97; Ptrend=0.74). These associations did 
not differ significantly by menopausal status at cancer diagnosis or hormone receptor status of 
tumors. 
Conclusions. Results from our updated analyses of rotating night shift work and breast cancer 
risk are consistent with long-term rotating night shift work being associated with an increased 
risk of breast cancer. The addition of follow-up time in NHS, which occurred primarily post 
retirement, eliminated a previously observed increase in risk in these women and suggests that 
their heightened risk may wane with time. 
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INTRODUCTION 
 Breast cancer is the most common cancer among women worldwide.[1] The noticeably 
higher prevalence in industrialized nations compared with developing countries suggests that 
environmental aspects of modern society may play an important role in breast cancer etiology.[2] 
Disruption of the circadian system with exposure to light during the environmental nighttime 
hours as with occupational night shift work schedules has been hypothesized to influence 
carcinogenesis through suppression of melatonin, modulation of sex hormones, or altered 
expression of peripheral clock genes.[3-6] Supporting epidemiologic studies as well as strong 
mechanistic data from animal studies led the International Agency for Research on Cancer 
(IARC) to classify night shift work that involves circadian disruption as probably carcinogenic to 
humans (group 2A) in 2007.[7] 
Since the IARC report, five meta-analyses have been published in an effort to summarize 
the growing literature on the association between night shift work and breast cancer risk, with 
varying approaches and conclusions. He et al, Wang et al, and Jia et al found moderate increased 
risk of breast cancer with night shift work, reporting pooled estimates in the range of 1.19-
1.20.[8-10] The overall estimate from Kamdar et al was similar in magnitude but was marginally 
significant.[11] Based only on case-control studies, Ijaz et al reported a 9% increased risk of 
breast cancer for every 5 years of night shift work[12] and He et al reported a 16% increased risk 
of breast cancer for every 10 years of shift work.[8] Each of the meta-analyses cited significant 
heterogeneity across studies, with differing results by type and quality of study. For all, there was 
insufficient evidence from cohort studies alone to draw a conclusion about the relationship of 
shift work and breast cancer risk. 
4 
 
Among the three cohort studies published since the IARC decision, two found 
statistically significant positive associations[13, 14] and one found no evidence of an 
association[15]. However, they were limited by their small sample sizes (Knutsson et al N=4036, 
Akerstedt et al N=13,656) or short follow-up time (Pronk et al less than 5 yrs for self-reported 
shift work exposure).  
The Nurses’ Health Study (NHS) and Nurses’ Health Study II (NHS2) were among the 
few cohort study analyses with prospectively collected shift work exposure that informed the 
2007 IARC decision.[16, 17] With double the follow-up time and twice as many breast cancer 
cases, we are now also able to investigate timing of risk and as well as breast cancer tumor 
markers. 
METHODS 
The NHS was established in 1976 when 121,701 female registered nurses, ages 30-55, 
returned a mailed questionnaire with detailed information about their lifestyles, occupational and 
environmental exposures, medication use, and medical conditions. The NHS2 was established in 
1989 when 116,430 female registered nurses, ages 25-42, returned a similar questionnaire. 
Participants in both cohorts have provided updated information biennially thereafter, and 
cumulative follow-up in the cohorts is >90%. Both studies are currently ongoing. The 
Institutional Review Board of Brigham & Women’s Hospital (Boston, MA) approved both 
studies, and all participants provided informed consent through the return of the initial 
questionnaire.  
Exposure assessment 
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Rotating night shift work duration was assessed through self-reported answers to the 
following question: “What is the total number of years during which you worked rotating night 
shifts (at least 3 nights/month in addition to days/evenings in that month)?” in 1988 for NHS and 
in 1989 for NHS2. In NHS2, a cumulative shift work measure was determined by adding 
baseline history to subsequently updated shift work information, collected in 1991, 1993, 1997, 
2001, 2005 and for a subset or women with email addresses who were sent an online 
questionnaire in 2007 (N=35,418, 34% of participants active in 2007).  
Each question that followed a gap in exposure assessment was asked in such a way as to 
allow for determination of months of shift work accumulated in each prior two-year cycle. In 
addition, the 2001 questionnaire asked about shift work in the period 1995-1997. Answers were 
very similar to those given on the 1997 questionnaire (Pearson’s r=0.53, p<0.0001), indicating 
that recall of shift work information to fill in gaps was reasonably comparable to real-time 
collected information. If no shift work information was available for a given cycle, the value 
from the previous cycle was used to fill in the missing information. If the information was also 
missing in the previous cycle, participants were excluded from analyses for that cycle and 
subsequent cycles until or if information was again provided (i.e. they contributed person-time 
only as long as exposure status was captured). Of those asked about current shift work exposure 
in 2007, only 8% were still working rotating night shifts. Therefore, for 2009 and subsequent 
cycles when shift work duration was not assessed, zero shift work was assumed. 
Outcome assessment 
Breast cancer cases were identified as having occurred during the period June 1, 1988 to 
June 1, 2012 (NHS) and June 1, 1989 to June 1, 2013 (NHS2). Nurses who reported breast 
cancer were asked for permission to review their medical records, and breast cancer was 
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confirmed through review of these records.  When medical records were unavailable, breast 
cancer subjects were included in the analysis if they were corroborated by a phone interview or 
written confirmation from the subject. Approximately two-thirds of the deaths among cohort 
members were reported to us by next of kin or the postal system in response to follow-up 
questionnaires. In addition, we searched the National Death Index to identify deaths due to breast 
cancer among the non-respondents from each two-year questionnaire. Only confirmed invasive 
breast cancers (i.e. excluding breast cancer in situ) were used in these analyses.  
For secondary analyses of breast cancer by hormone receptor status, estrogen receptor 
(ER) and progesterone receptor (PR) status were determined by immunohistochemical staining 
of tumor tissue. The breast cancer tissue collection, tissue microarray (TMA) construction, and 
staining and reading for tumor markers has been described in detail elsewhere.[18] When TMA 
results were unavailable, medical record documentation of ERPR status was used instead. ER 
and PR status was not available for 14% of the cancers in NHS and 7% of the cancers in NHS2 
Study population for analysis 
At baseline (1988 in NHS and 1989 in NHS2), there were 103,415 participants in NHS, 
and 116,430 women in NHS2. Of these, participants with prior cancers except non-melanoma 
skin cancer (NHS: 7,957 (8%); NHS2: 1,050 (1%)) and those who did not answer the initial shift 
work history question (NHS: 16,942 (16%); NHS2: 581 (<1%)) were excluded. The remaining 
datasets for analysis comprised 78,516 women, ages 42-67, in NHS and 114,559 women, ages 
24-42, in NHS2.  
Covariate assessment 
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The following covariates were collected by questionnaire and were considered for 
inclusion in all multivariable-adjusted models as potential confounders or breast cancer risk 
factors in both cohorts, unless otherwise noted: height, body mass index (BMI), BMI at age 18, 
childhood body size (average of age 5 and age 10 diagrams), adolescent body size (average of 
age 10 and age 20 diagrams), age at menarche, oral contraceptive use, age at first birth, parity, 
breastfeeding duration, menopausal status, type of menopause (natural or surgical), age at 
menopause, menopausal hormone therapy (MHT) use and duration of types of MHT, first degree 
family history of breast cancer, personal history of benign breast disease, smoking status and 
frequency, alcohol consumption, nurse’s highest education level (NHS only), husband’s highest 
education level, and mammography use.  
As several covariates have common reference categories, combination variables were 
created to allow for multiple factors to be used in the same model. Specifically, age at first birth 
and parity were combined and categorized as nulliparous, age <25 yrs and 1-2 children, age <25 
yrs and 3+ children, age 25-29 and 1-2 children, age 25-29 and 3+ children, age 30+ and 1-2 
children, and age 30+ and 3+ children in NHS. In NHS2, a younger cohort at baseline, broader 
categories were needed: nulliparous, parous and age <25 yrs, parous and age 25-29, and parous 
and age 30+. In both cohorts, menopausal status, type of menopause and age at menopause were 
combined and categorized as premenopausal, natural menopause age <45 yrs, natural menopause 
age 45+ yrs, surgical menopause age <45 yrs, surgical menopause age 45+ yrs. See Table 2 
footnotes for specific categorizations of other covariates. 
All variables except for height and duration of MHT by type were included in 
multivariable models as categorical variables with missing indicators. Less than 1% of 
participants were missing information on height and were excluded. Those with missing duration 
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of MHT by type were given the value of 0 months of MHT. BMI was carried forward for one 
questionnaire cycle to fill in some missing BMI (NHS: 9% missing reduced to 3% after carrying 
forward; NHS2: 14% reduced to 7%). 
Statistical analyses 
Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% 
confidence intervals (CI) over the entire follow-up period. As shift work exposure assessment 
differed by cohort (i.e. not updated in NHS; updated in NHS2), models are presented separately 
for each cohort. Women were categorized according to the duration of rotating night shift work 
(NHS: never, 1-14 years, 15-29 years, 30+ years; NHS2: never, 1-9 years, 10-19 years, 20+ 
years). All models were simultaneously adjusted for age in months and time period in two-year 
intervals. Participants were censored at the time of breast cancer diagnosis, diagnosis of other 
cancer (except non-melanoma skin cancer) or death, whichever came first.  
Multivariable models were adjusted for breast cancer risk factors and possible 
confounders of the shift work and breast cancer association. Each covariate was added into the 
age-adjusted model individually to see if the exposure-outcome associations changed 
appreciably. All covariates were included in the final multivariable-adjusted model because they 
either changed the estimate (i.e. they were confounders) or were associated with the outcome and 
thereby improved precision. Childhood body size and adolescent body size were highly 
correlated, so only adolescent body size was used as it was more strongly related to the outcome. 
See Table 2 footnotes for the complete list of covariates included in the multivariable models. 
We performed tests for trend with continuous exposure measures using the midpoint of 
shift work duration categories and truncating the highest category. All p-values are two-sided 
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and values less than 0.05 were considered statistically significant. SAS software, version 9.3 
(SAS Institute, Cary, North Carolina, United States) was used for all statistical analyses. 
Secondary analyses 
As similar main analyses with approximately half the follow-up time were previously 
published,[16, 17] we stratified by follow-up time period to separate early vs. late effects of 
rotating night shift work on breast cancer risk (i.e. ≤10 and >10 years of follow-up). To 
investigate the relationship of breast cancer risk with recency of night shift work exposure, we 
also ran models using an exposure variable separating never, current and past shift work, with 
categories for different times since stopping shift work, in the full dataset as well as a reduced 
dataset restricted to ever shift workers. Since updated shift work information was needed, this 
analysis was only possible in NHS2. Women were deemed to have stopped shift work at the last 
cycle with reported shift work information, regardless of whether there were prior cycles with no 
reported shift work.  
We also ran models stratified by menopausal status and breast cancer hormonal receptor 
status of tumors (ER+PR+, ER+PR-, ER-PR-), as these attributes of breast cancer cases may 
inform etiologic interpretation of results. ER-PR+ tumor status was considered to be an artifact 
of reading[19] and was not included as a subtype. Cases of other subtypes and those missing 
ERPR subtype were treated as censored events in this competing risks analysis. Wald tests for 
interaction were used for analyses stratified by follow-up and menopausal status. The Likelihood 
Ratio Test was used to test for heterogeneity among the results by ER and PR status.  
In NHS2, updated exposure information allowed us to separate shift work duration by 
time accrued pre- and postmenopausally. We ran models to assess the relationship of 
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premenopausal shift work and postmenopausal shift work and breast cancer, excluding 2731 
(2%) participants who were postmenopausal at baseline as we were unable to attribute reported 
shift work duration to either the pre- or postmenopausal period. Both measures of shift work 
were treated as continuous variables and included in the models together to determine the 
associations independent of the other measure. 
All multivariable models were adjusted for mammogram in the past 2 years (yes, no), as 
it predicts breast cancer diagnosis. To further account for possible bias due to mammography 
screening (i.e. shift workers may be less likely to seek screening and therefore be less likely to be 
diagnosed with breast cancer), we also performed a secondary analysis using inverse probability 
weighting by predicted mammography use.[20] 
RESULTS 
The participants in the NHS and NHS2 cohorts included in our analyses showed several 
general patterns in the distribution of baseline characteristics between cohorts and across 
categories of shift work (see Table 1). Participants in the NHS sample were roughly 20 years 
older than those in NHS2, and those in the highest shift work category were approximately 6 
years older than those with no shift work exposure in both cohorts. In addition, in both cohorts, 
women at baseline with the highest level of shift work (30+ years in NHS, 20+ years in NHS2) 
were heavier, more likely to have had menarche before age 12, more likely to be current smokers 
with more pack-years of smoking, but with lower consumption of alcohol, compared with never 
shift workers. They also had a lower percentage with benign breast disease, although this could 
be due to their lower mammography use. 
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Table 1. Age-adjusted baseline characteristics by categories of rotating night shift work duration (NHS: 1988, N=78,516; NHS2: 1989, 
N=114,559) 
 
  NHS NHS2 
  Never 1-14 years 15-29 years 30+ years Never 1-9 years 10-19 years 20+ years 
Characteristic n=31,746 n=40,966 n=4,424 n=1,380 n=43,529 n=65,783 n=5,085 n=162 
Age 54.3  (7.2) 54.7 (7.1) 56.1 (6.9) 60.4 (4.6) 34.8 (4.7) 34.6 (4.7) 37.2(3.4) 41.0 (2.4) 
Height, inches 64.5 (2.4) 64.5 (2.4) 64.4 (2.5) 64.5 (2.5) 64.9 (2.6) 64.9 (2.6) 64.9 (2.7) 63.9 (2.9) 
BMI, kg/m2 25.3 (4.8) 25.6 (4.9) 27.0 (5.5) 26.6 (5.2) 23.9 (4.9) 24.1 (5.1) 25.3 (5.9) 24.8 (5.8) 
BMI at age 18, kg/m2 21.2 (2.9) 21.3 (3.0) 21.9 (3.4) 21.9 (3.7) 21.2 (3.2) 21.3 (3.4) 22.0 (4.1) 21.3 (4.2) 
Childhood body size a 2.4 (1.3) 2.4 (1.3) 2.4 (1.4) 2.3 (1.4) 2.6 (1.2) 2.6 (1.2) 2.7 (1.3) 2.6 (1.3) 
Adolescent body size a 2.7 (1.2) 2.7 (1.2) 2.7 (1.3) 2.7 (1.3) 2.9 (1.1) 2.9 (1.1) 3.0 (1.2) 2.7 (1.2) 
Menarche before age 12 22 23 24 30 24 25 29 35 
Ever oral contraceptive use 49 49 46 44 83 83 83 57 
Nulliparous 5 6 6 6 28 32 36 42 
Number of children b 3.2 (1.5) 3.1 (1.5) 3.2 (1.6) 3.2 (1.6) 2.1 (0.9) 2.0 (0.9) 2.1 (0.9) 2.0 (0.7) 
Age at first birth b 24.9 (3.2) 25.3 (3.4) 24.9 (3.5) 25.3 (3.1) 25.2 (4.0) 25.7 (4.1) 25.3 (4.1) 23.0 (3.5) 
Ever breastfed b 47 49 47 43 48 46 39 32 
Postmenopausal 67 68 70 86 2 2 3 4 
Age at menopause c 48.8 (4.8) 48.7 (4.8) 48.3 (4.7) 48.4 (4.3) 37.7 (4.3) 37.5 (4.7) 37.4 (3.6) 40.4 (0.8) 
Menopause due to surgery c 41 42 44 40 93 92 96 88 
Current menopausal hormone therapy use c 35 35 29 29 83 79 84 82 
First-degree family history of breast cancer 11 11 11 12 6 6 5 2 
History of benign breast disease 37 38 34 30 28 29 27 17 
Current smoker 17 19 25 25 12 13 19 23 
Pack-years smoked d 23.1 (19.5) 23.2 (19.4) 26.1 (20.0) 26.2 (20.0) 11.4 (8.2) 11.3 (8.2) 11.8 (8.3) 12.3 (7.6) 
Alcohol consumption, grams/day 6.1 (10.6) 6.3 (10.7) 5.3 (10.5) 5.5 (9.7) 3.0 (6.0) 3.2 (6.1) 2.9 (6.1) 1.3 (4.4) 
Physical activity, MET-hours/week 14.6 (20.8) 16.0 (21.9) 16.1 (21.7) 19.3 (28.3) 22.7 (34.2) 26.0 (37.9) 32.8 (48.4) 25.7 (56.2) 
Nurse’s education level bachelor's or higher e 31 30 24 22  -- -- -- --  
Husband's education level college or higher f 55 56 42 49 80 83 80 90 
Ever had mammogram 77 76 70 72 38 37 34 29 
Values are means (SD) or percentages and are standardized to the age distribution of the study population.  
a Body size recalled using pictures of body outlines, numbered 1-9, leanest to fattest (NHS: 1988, NHS2: 1989) 
b Among parous women only. 
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c Among postmenopausal women only. 
d Among smokers only. 
e Nurse's own education level. (NHS only: 1992) 
f Among married or widowed women only. (NHS: 1992; NHS2: 1999) 
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Women were much more likely to be nulliparous in NHS2 (28-42%), compared with 
NHS (5-6%). Women with the longest shift work history were more likely to be nulliparous in 
NHS2, although, among parous, their age at first birth was lower than it was for the comparable 
group in NHS. Ever oral contraceptive and current MHT was higher in NHS2 compared with 
NHS. 
In NHS, the women with the highest duration of shift work were less likely to have 
attained education levels above bachelor’s degrees and less likely to have had husbands with 
education level above college. In NHS2, we did not have a measure of SES until spousal 
education attainment was collected in 1999 (10 years post baseline). Using this measure, the 
highest shift work group in NHS2 at baseline had the highest spousal education attainment. 
However, it should be noted that by the approximate midpoint of follow-up in 1999, the highest 
shift work group had lower spousal education attainment, similar to NHS at baseline (data not 
shown). 
During 24 years of follow-up, we documented 9541 total invasive breast cancers (5971 in 
NHS and 3570 in NHS2), with a median time to breast cancer event of 13 years in NHS and 14 
years in NHS2. NHS2 cumulative shift work analyses included 3188 breast cancers, due to 
skipping of cycles with missing updated shift work information as previously described. 
In NHS, we observed no association between baseline duration of rotating night shift 
work and breast cancer risk in age-adjusted models, with never shift workers as the reference 
group (HR1-14 yrs vs 0 yrs =1.03, 95% CI 0.98-1.09; HR15-29 yrs vs 0 yrs =1.02, 95% CI 0.91-1.14; HR30+ 
yrs vs 0 yrs =0.92, 95% CI 0.75-1.13; ptrend=0.89). Adjustment for possible confounders and breast 
cancer risk factors resulted in minimal change to these null results (MV-HR1-14yrs=1.01, 95% CI
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Table 2. Associations of duration of rotating night shift work and invasive breast cancer during 24 years of follow-up (NHS: 1988-2012; 
NHS2: 1989-2013) 
 
  No. of cases Person-years 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) b 
NHS rotating night shift work history         
     Never 2382 640,594 Ref Ref 
     1-14 yrs 3162 817,778 1.03 (0.98-1.09) 1.01 (0.96-1.07) 
     15-29 yrs 331 84,887 1.02 (0.91-1.14) 1.06 (0.94-1.19) 
     30+ yrs 96 25,178 0.92 (0.75-1.13) 0.95 (0.77-1.17) 
  5971 1,568,438 ptrend = 0.89 ptrend = 0.63 
NHS2 1989 baseline rotating night shift work history 
(early career)       
     Never 1318 978,847 Ref Ref 
     1-9 yrs 2071 1,475,921 1.06 (0.99-1.13) 1.05 (0.98-1.13) 
     10-19 yrs 168 112,752 0.94 (0.80-1.10) 1.00 (0.85-1.17) 
     20+ yrs 13 3,335 1.83 (1.05-3.17) 2.15 (1.23-3.73) 
  3570 2,570,855 ptrend = 0.58 ptrend = 0.23 
NHS2 cumulative rotating night shift work (updated) a       
     Never 950 675,209 Ref Ref 
     1-9 yrs 2002 1,384,743 1.03 (0.96-1.12) 1.04 (0.96-1.12) 
     10-19 yrs 201 140,868 0.90 (0.77-1.05) 0.94 (0.81-1.10) 
     20+ yrs 35 13,705 1.29 (0.92-1.81) 1.40 (1.00-1.97) 
  3188 2,214,524 ptrend = 0.73 ptrend = 0.74 
 
a For NHS2, analyses using updated duration of shift work excluded participants during the cycles in which they were missing shift work exposure information, resulting in fewer 
cases and person-years, compared to analyses using history of shift work reported at baseline in 1989. 
b Multivariable-adjusted models include the following covariates: age (months), height (continuous in inches), BMI (<18.5, 18.5-24.9, 25.0-29.9, 30+ kg/m2), BMI at age 18 
(<18.5, 18.5-24.9, 25.0-29.9, 30+ kg/m2), adolescent body size (average of age 10 and age 20 diagrams: 1, 1.5-2, 2.5-3, 3.5-4, 4.5+), age at menarche (<12 yrs, 12-13 yrs, 14+ yrs), 
age at first birth and parity combined (NHS: nulliparous, age <25 yrs 1-2 children, age <25 yrs 3+ children, age 25-29 yrs 1-2 children, age 25-29 yrs 3+ children, age 30+ yrs 1-2 
children, age 30+ yrs 3+ children; NHS2: nulliparous, parous age <25 yrs, parous age 25-29 yrs, parous age 30+ yrs), breastfeeding (NHS: none, 1-11 months, 12+ months; NHS2: 
none, 1-12 months, >12 months), type of menopause and age at menopause combined (premenopausal, post natural age <45, post natural age 45+, post surgery age <45, post 
surgery age 45+), menopausal hormone therapy (never, past, current), duration of estrogen alone MHT (continuous in months), duration of estrogen and progesterone MHT 
(continuous in months), first-degree family history of breast cancer (yes, no), history of benign breast disease (yes, no), alcohol consumption (0, 0.1-14, 14.1-28, >28g/day), 
physical activity (<=8, 8.1-16, 16.1-24, >24 MET-hrs/week), and current mammography use (yes, no). All categorical covariates were included in models with missing indicators.
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0.96-1.07; MV-HR15-29 yrs vs 0 yrs =1.06, 95% CI 0.94-1.19; MV-HR30+ yrs vs 0 yrs =0.95, 95% CI 
0.77-1.17; ptrend=0.63). (See Table 2) 
By contrast, in NHS2, 20+ years of rotating night shift work at baseline was associated 
with a significantly increased risk of breast cancer, compared with baseline never shift work, in 
both the age-adjusted model (HRbase20+ yrs vs 0 yrs =1.83, 95% CI 1.05-3.17, ptrend=0.58) and the 
multivariable-adjusted model (MV-HRbase20+ yrs vs 0 yrs =2.15, 95% CI 1.23-3.73, ptrend=0.23). We 
observed no association between shorter durations of shift work at baseline and breast cancer 
risk. Women with cumulative rotating night shift work exposure of 20+ years had a marginally 
significant increased risk of breast cancer, compared to women who never worked rotating night 
shifts (age-adjusted model HRcum20+ yrs vs 0 yrs =1.29, 95% CI 0.92-1.81; MV-adjusted model 
HRcum20+ yrs vs 0 yrs =1.40, 95% CI 1.00-1.97, ptrend=0.74). Results were null for the other durations 
of shift work. (See Table 2) 
Stratification by follow-up period in both cohorts and both measures of shift work in 
NHS2 showed a general pattern of increased risk with the highest level of shift work duration 
during the first 10 years of follow-up, which was not apparent in the remainder of the full follow-
up. In NHS, the trend across categories in the first 10 years was statistically significant 
(ptrend=0.04), and the HR for 30+ years of shift work was non-significantly elevated (MV-HR30+ 
yrs vs 0 yrs=1.26, 95% CI 0.97-1.64). In the last 14 years of follow-up, the HR was inverse (MV-
HR30+yrs=0.68, 95% CI 0.49-0.95), with pinteraction=0.03. In NHS2, the HRs for baseline 20+ yrs as 
well as cumulative 20+ years were significantly positive in the first 10 years of follow-up (MV-
HRbase 20+ yrs vs 0 yrs=2.35, 95% CI 1.04-5.31 and MV-HRcum 20+ yrs vs 0 yrs=2.13, 95% CI 1.19-3.81, 
respectively), and non-significantly positive with lower estimates in the last 14 years of follow-
up (MV-HRbase 20+ yrs vs 0 yrs =1.95, 95% CI 0.92-4.15 and MV-HRcum 20+ yrs vs 0 yrs=1.19, 95% CI:
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0.78-1.81, respectively). Interactions with follow-up period were not significant in NHS2. (See 
Table 3)  
 We observed no significant associations with breast cancer risk for current or past shift 
work with different times since stopping working night shifts, compared with never shift work. 
When restricted to women who ever worked rotating night shifts, we noted a significant trend for 
increasing risk of breast cancer with greater time since stopping shift work (Ptrend=0.04; Table 4). 
Using the same categories of rotating night shift work as in the main analyses, we were 
only able to stratify by menopausal status in NHS2 because of the small number of 
premenopausal cases in the highest level of shift work exposure in NHS. Baseline 20+ years of 
shift work was significantly associated with postmenopausal breast cancer (MV-HR20+ yrs vs 0 yrs, 
postmeno=3.24, 95% CI 1.68-6.25), although this level of shift work had few cases (n=10), and the 
interaction between shift work and menopausal status was not significant (pinteraction=0.17). The 
cumulative shift work and breast cancer results were null and did not differ by menopausal status 
(pinteraction =0.22). In addition, neither measure of shift work duration accrued 
pre/postmenopausally was associated with breast cancer in multivariable-models, adjusting for 
the other measure (MV-HRpreSW=1.00, 95% CI 0.99-1.01; MV-HRpostSW=0.98, 95% CI 0.90-
1.06). 
The associations of shift work and breast cancer did not differ by ER and PR status of the 
breast cancer in both cohorts across the full follow-up period (NHS pheterogeneity=0.18; NHS2 
baseline pheterogeneity=0.48; NHS2 cumulative pheterogeneity=0.70), although small sample sizes in the 
highest shift work categories limit interpretability (See Table 5). Restricting to ER+PR+ tumors 
only, the association of cumulative rotating shift work and breast cancer in NHS2 was 
strengthened (MV-HRcum 20+ yrs vs 0 yrs=1.62, 95% CI 1.07-2.45), when compared with the main
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Table 3. Associations of duration of rotating night shift work and invasive breast cancer, stratified by follow-up period, during 24 years of 
follow-up (NHS: 1988-2012; NHS2: 1989-2013) 
 
  Follow-up <=10 years Follow-up >10 years   
  
No. of 
cases 
Person-
years 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) b 
No. of 
cases 
Person-
years 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) b 
MV 
pinteraction 
NHS rotating night shift work history                   
     Never 977 298,701 Ref Ref 1405 336,729 Ref Ref   
     1-14 yrs 1415 383,622 1.11 (1.02-1.21) 1.09 (1.00-1.18) 1747 427,392 0.97 (0.91-1.05) 0.96 (0.89-1.03)   
     15-29 yrs 146 40,739 1.03 (0.86-1.23) 1.07 (0.90-1.28) 185 43,381 1.01 (0.87-1.18) 1.05 (0.90-1.23)   
     30+ yrs 60 12,537 1.23 (0.95-1.60) 1.26 (0.97-1.64) 36 12,418 0.65 (0.47-0.91) 0.68 (0.49-0.95)   
  2598 735,599 ptrend = 0.08 ptrend = 0.04 3373 819,920 ptrend = 0.15 ptrend = 0.25 pint = 0.03 
NHS2 1989 baseline rotating night shift 
work history (early career)               
     Never 416 412,724 Ref Ref 902 553,730 Ref Ref   
     1-9 yrs 637 622,782 1.03 (0.91-1.17) 1.02 (0.90-1.15) 1434 833,620 1.07 (0.98-1.16) 1.07 (0.98-1.16)   
     10-19 yrs 57 47,867 0.94 (0.71-1.24) 0.96 (0.73-1.27) 111 63,327 0.94 (0.77-1.14) 1.01 (0.83-1.24)   
     20+ yrs 6 1,491 2.13 (0.95-4.80) 2.35 (1.04-5.31) 7 1,801 1.63 (0.77-3.45) 1.95 (0.92-4.15)   
  1116 1,084,864 ptrend = 0.76 ptrend = 0.71 2454 1,452,478 ptrend = 0.65 ptrend = 0.24 pint = 0.85 
NHS2 cumulative rotating night shift 
work (updated) a               
     Never 341 321,600 Ref Ref 609 346,804 Ref Ref   
     1-9 yrs 621 602,095 0.98 (0.86-1.12) 0.97 (0.85-1.11) 1381 767,303 1.06 (0.96-1.16) 1.07 (0.97-1.18)   
     10-19 yrs 60 50,481 0.92 (0.70-1.21) 0.94 (0.71-1.23) 141 88,801 0.90 (0.74-1.07) 0.95 (0.79-1.14)   
     20+ yrs 12 2,956 1.99 (1.11-3.56) 2.13 (1.19-3.81) 23 10,637 1.10 (0.72-1.66) 1.19 (0.78-1.81)   
  1034 977,132 ptrend = 0.83 ptrend = 0.75 2154 1,213,546 ptrend = 0.58 ptrend = 0.89 pint = 0.73 
 
a For NHS2, analyses using updated duration of shift work excluded participants during the cycles in which they were missing shift work exposure information, resulting in fewer 
cases and person-years, compared to analyses using history of shift work reported at baseline in 1989. 
 
b Multivariable-adjusted models. See Table 2 footnotes for list of covariates. 
 
  
18 
 
Table 4. Associations of time since stopping rotating night shift work and invasive breast cancer during 24 years of follow-up in NHS2 only 
(1989-2013) 
 
  No. of cases Person-years 
Age-adjusted HR 
(95%CI) 
Multivariable-
adjusted                         
HR (95% CI) a 
NHS2 time since stopping rotating night shift work among 
all       
     Never shift work 1060 786,772 Ref Ref 
     Current shift work 478 467,992 0.97 (0.87-1.09) 0.96 (0.84-1.09) 
     Past, <=8 years since stopping shift work 798 606,237 1.01 (0.92-1.11) 1.01 (0.91-1.13) 
     Past, 9-16 years since stopping shift work 907 476,794 1.08 (0.98-1.19) 1.10 (0.99-1.22) 
     Past, >16 years since stopping shift work 327 233,060 1.09 (0.94-1.27) 1.10 (0.95-1.28) 
  3570 2,570,855   
NHS2 time since stopping rotating night shift work, 
restricted to ever rotating night shift workers only     
 
     Current shift work (i.e. 0 years since stopping) 478 467,992 Ref Ref 
     Past, <=8 years since stopping shift work 798 606,237 1.03 (0.92-1.17) 1.05 (0.93-1.19) 
     Past, 9-16 years since stopping shift work 907 476,794 1.11 (0.97-1.27) 1.14 (0.99-1.31) 
     Past, >16 years since stopping shift work 327 233,060 1.17 (0.96-1.43) 1.19 (0.97-1.47) 
  2510 1,784,083 Ptrend=0.06 Ptrend=0.04 
 
a Multivariable-adjusted models are adjusted for the covariates listed in Table 2 footnotes, and are additionally adjusted for duration of rotating night shift work (continuous in 
months). 
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Table 5. Associations of duration of rotating night shift work and estrogen receptor (ER) and progesterone receptor (PR) status a of invasive 
breast cancer tumors during 24 years of follow-up (NHS: 1988-2012; NHS2: 1989-2013) 
 
  ER+PR+ ER+PR- ER-PR-   
  
No. of 
cases 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) c 
No. of
cases 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) c 
No. of 
cases 
Age-adjusted 
HR (95%CI) 
Multivariable-
adjusted                         
HR (95% CI) c 
MV
pheterogeneity 
NHS rotating night shift work history                   
     Never 1390 Ref Ref 319 Ref Ref 327 Ref Ref   
     1-14 yrs 1879 1.05 (0.98-1.13) 1.03 (0.96-1.10) 414 1.00 (0.86-1.16) 0.98 (0.85-1.14) 398 0.95 (0.82-1.10) 0.94 (0.81-1.09)   
     15-29 yrs 199 1.05 (0.90-1.22) 1.11 (0.95-1.29) 34 0.76 (0.53-1.08) 0.82 (0.57-1.17) 45 1.01 (0.74-1.38) 1.06 (0.77-1.45)   
     30+ yrs 54 0.92 (0.70-1.21) 0.96 (0.73-1.27) 11 0.74 (0.40-1.35) 0.77 (0.42-1.40) 8 0.59 (0.29-1.20) 0.63 (0.31-1.27)   
  3522 ptrend = 0.56 ptrend = 0.33 778 ptrend = 0.12 ptrend = 0.21 778 ptrend = 0.34 ptrend = 0.47 phet= 0.18 
NHS2 1989 baseline rotating night shift 
work history (early career)                  
     Never 708 Ref Ref 112 Ref Ref 200 Ref Ref   
     1-9 yrs 1166 1.11 (1.01-1.22) 1.11 (1.01-1.22) 201 1.21 (0.96-1.52) 1.21 (0.96-1.52) 268 0.90 (0.75-1.08) 0.92 (0.76-1.11)   
     10-19 yrs 87 0.90 (0.72-1.13) 0.97 (0.78-1.22) 16 1.03 (0.61-1.74) 1.14 (0.67-1.93) 23 0.88 (0.57-1.35) 0.95 (0.61-1.47)   
     20+ yrs 5 1.33 (0.55-3.22) 1.58 (0.65-3.83) 1 1.29 (0.18-9.35) 1.58 (0.21-11.72) 2 2.08 (0.51-8.47) 2.15 (0.52-8.92)   
  1966 ptrend = 0.67 ptrend = 0.31 330 ptrend = 0.41 ptrend = 0.25 493 ptrend = 0.44 ptrend = 0.70 phet= 0.48 
NHS2 cumulative rotating night shift 
work (updated) b                  
     Never 539 Ref Ref 81 Ref Ref 146 Ref Ref   
     1-9 yrs 1152 1.04 (0.94-1.15) 1.04 (0.94-1.16) 204 1.24 (0.96-1.61) 1.25 (0.97-1.62) 269 0.90 (0.73-1.10) 0.92 (0.75-1.12)   
     10-19 yrs 105 0.81 (0.66-1.00) 0.85 (0.69-1.05) 20 1.09 (0.67-1.78) 1.20 (0.73-1.96) 42 1.22 (0.86-1.72) 1.29 (0.91-1.82)   
     20+ yrs 24 1.50 (1.00-2.27) 1.62 (1.07-2.45) 2 0.79 (0.19-3.24) 0.89 (0.22-3.64) 2 0.50 (0.12-2.02) 0.53 (0.13-2.14)   
  1820 ptrend = 0.53 ptrend = 0.89 307 ptrend = 0.60 ptrend = 0.36 459 ptrend = 0.74 ptrend = 0.54 phet= 0.70  
 
a ERPR status was not available for 14% of the cancers in NHS and 7% of the cancers in NHS2. ER-PR+ tumor status was considered to be an artifact of reading[19] and was not 
included as a subtype. 
 
b For NHS2, analyses using updated duration of shift work excluded participants during the cycles in which they were missing shift work exposure information, resulting in fewer 
cases and person-years, compared to analyses using history of shift work reported at baseline in 1989. 
 
c Multivariable-adjusted models. See Table 2 footnotes for list of covariates. 
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result in Table 2. Combining the highest two categories of shift work for both cohorts to better 
balance number of women in each exposure category showed resulted in null findings with no 
significant heterogeneity by ER/PR status (data not shown). 
The results from secondary analyses using inverse probability weighting for 
mammographic screening were not substantially different from the main results using traditional 
model adjustment for current mammography use. Reduced sample sizes were available for the 
IPW models because no weights could be determined if mammography use information was 
missing, so comparisons were made between models using traditional adjustment and IPW 
weighting utilizing the same smaller dataset. In both cohorts, the multivariable-adjusted hazard 
ratios were similar to our unweighted results (NHS unweighted HR30+ yrs vs 0 yrs =0.97 vs. 
weighted HR30+ yrs vs 0 yrs =1.00; NHS2 unweighted HRbase20+ yrs vs 0 yrs =2.60 vs. weighted HRbase20+ 
yrs vs 0 yrs =2.55 and unweighted HRcum20+ yrs vs 0 yrs =1.41 vs. weighted HRcum20+ yrs vs 0 yrs =1.51), 
indicating minimal bias due to differential screening practices among shift workers. 
DISCUSSION 
We saw no association between rotating night shift work and breast cancer incidence 
over the full 24 years of follow-up in the NHS cohort. The women included in this analysis were 
42-67 years old at baseline in 1988, when shift work history was recorded. Current rotating night 
shift work (yes/no) was asked of the cohort 8 years later in 1996, and only 3% were still working 
rotating night shifts at that time. We seem to have captured primarily post-retirement time with 
the expansion of follow-up and likely very little additional shift work was accumulated. This 
may in part explain the lack of an association we observed in NHS with the additional 14 years 
of follow-up. 
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In NHS2, the younger age of the cohort as well as updated exposure information 
throughout follow-up allowed us to assess breast cancer risk with more recent shift work 
exposure. We found a strong positive association with breast cancer among the women who had 
accumulated 20+ years of rotating night shift work early in their careers, in their 20’s and 30’s. 
Those participants also contributed to the 20+ year shift work category in the cumulative shift 
work measure, but were mixed with women who had different patterns of shift work 
accumulation after baseline, likely attenuating this association. Nonetheless, the cumulative 
measure of shift work was consistent with a marginally significant increased risk of breast 
cancer.  
To explore this further, we conducted analyses restricting to ever shift workers, and 
observed a significant trend with longer time since stopping shift work being associated with 
greater breast cancer risk in these women. In 2009, women in NHS2 were asked about their 
primary work schedule during the age ranges of 20-25, 26-35, 36-45 and 46+. For the person-
time attributed to the >16 years of time since stopping shift work category, 94% reported being 
rotating night shift workers before age 35 (compared with 67% for current, 82% for <=8 years 
since stopping, and 89% for 9-16 years since stopping shift work). Hence, greater time since 
stopping shift work may be a marker for shift work performed at young adult ages. 
We explored the associations separately for the first 10 years of follow-up and the 
remaining 14 years of follow-up, to understand the long-term findings in the context of our 
previously published shorter-term associations.[16, 17] In both cohorts, and for both measures of 
shift work in NHS2, we saw that breast cancer risk associated with night shift work was higher in 
the earlier versus later portion of follow-up. The estimates were higher in NHS2, where the shift 
work performance was likely closer in proximity to breast cancer risk than in NHS. We 
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investigated the suggestive inverse finding in the later part of follow-up for NHS as possibly 
reflecting a healthy worker effect, but did not see any evidence of differential dropping out of the 
analysis by shift work category, and therefore believe it to be due to chance. 
 To our knowledge, no other studies have specifically explored timing or proximity of 
shift work with breast cancer risk. However, duration of shift work may serve as a proxy for 
recency of exposure. Data from the Current Population Survey in the US[21] suggests that a 
large proportion of people who work night shifts do so to accommodate schooling and childcare 
needs, presumably at young ages. Other work from our group[22] suggests that most nurses in 
our cohorts who engage in shift work do so before age 25, possibly during training programs. 
Longer durations of shift work in this population likely include shift work that occurred during 
training and then continued on, closer to breast cancer diagnosis. In other populations, studies 
that have found a significant association with duration of shift work, have done so with durations 
of at least 15 years.[23-25] 
Further, timing of shift work with respect to breast tissue development may be critical. In 
our analyses, the strongest associations with breast cancer risk were for those women who 
worked 20+ years on rotating night shifts early in their careers as young adults. The early-career 
time in these nurses may be within a window of major breast tissue change – the period between 
onset of puberty and breast involution due to childbirth (postlactational) or aging (lobular) - and 
therefore vulnerable to cancer risk factors. In a recent Spanish study, Papantoniou et al saw a 
slightly higher risk of breast cancer among women exposed to night shift work prior to first full-
term pregnancy compared to those exposed after first full-term pregnancy.[26] Additional 
analyses in datasets that allow for separation of shift work exposure with respect to such early-
career events are warranted. 
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In addition, as circulating estradiol levels have been reported to be higher in night shift 
workers compared to day shift workers,[27] we evaluated the shift work and breast cancer 
association by presence of estrogen and progesterone receptors in the tumor tissue. Small 
numbers in the highest categories of shift work duration limited determination of statistically 
significant heterogeneity. However, NHS2 results indicated a potentially stronger association 
with ER+PR+, supporting the hypothesized hormonal pathway for shift work to affect breast 
cancer risk.  
Finally, as night shift workers are less likely to adhere to breast cancer screening 
guidelines28 and we noted lower proportion of mammography use with increasing shift work 
duration in our data (see Table 1), we ran models using inverse probability weights for likelihood 
of mammography based on factors that have been shown to predict screening behavior.[28] We 
saw little evidence of bias in our main results due to differential screening practices and it is 
unlikely that such bias may have distorted an association. 
The NHS and NHS2 cohorts provide rich data for examining the association of rotating 
night shift work and breast cancer, but also have several notable limitations. Rotating night shift 
work for a given month was defined as 3 or more night shifts on a rotating schedule in addition 
to other day/evening shifts in that month; in other words, a nurse with 20 years of night shifts, 
but not on a rotating shift schedule, would answer ‘none’ to this question. Also, although night 
shift workers may get more exposure to electric light at night than day shift workers, almost all 
persons in the modern world are exposed to light at night, at least in the evening. It has been 
shown from controlled studies in the laboratory that such lighting can delay melatonin onset and 
duration depending on intensity and wavelength.[29] Thus, our exposure definition itself may not 
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capture the intensity or pattern of night shift work that is most disruptive, and may have limited 
our ability to identify a dose-response relationship.  
Still, the NHS and NHS2 cohorts are among the largest prospective cohort studies 
available for quantifying the relationship between rotating night shift work and breast cancer. 
They are unique in their ability to prospectively measure night shift work as well as most of the 
lifestyle and reproductive factors that are important for breast cancer development. The studies 
also include long follow-up and a large number of breast cancer cases to allow exploration of 
risk patterns over time as well as some separation of effects for subtypes of breast cancer. 
The updated long-term findings in the NHS and NHS2 cohorts have important 
implications for future IARC evaluations of the shift work and breast cancer association. Our 
results may serve to put the literature into the context of short-term vs long-term effects, and 
suggest that there may be a period of increased risk, that wanes with time. 
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ABSTRACT 
Introduction. Mammographic density is a strong risk factor for breast cancer and is therefore 
considered to be a good intermediate marker of risk. Shift work that involves circadian 
disruption has been deemed a probable carcinogen by the International Agency for Research on 
Cancer (IARC) for its reported association with increased risk of breast cancer. However, to our 
knowledge, only one prior study has examined the association of shift work and mammographic 
density. 
Methods. We conducted a prospective analysis among women in the Nurses’ Health Study 
(NHS) and Nurses’ Health Study II (NHS2) who provided information on their rotating night 
shift work history and screening mammograms from which we were able to determine percent 
density (%), absolute dense area (cm2) and absolute non-dense area (cm2). Multivariable linear 
regression models were fit for each density measure separately, and were stratified a priori by 
menopausal status at the time of mammogram (Npre=1,906, Npost=1,860). Differences in mean 
density measures were reported for durations of 1-9 years, 10-19 years and 20+ years of rotating 
night shift work, and for current shift work, compared to never shift work. 
Results. Duration of rotating night shift work cumulative through time of mammogram was not 
associated with a statistically significant difference in mean mammographic density, compared to 
those with no rotating night shift work experience, in premenopausal women (βpct, 1-9 yrs vs 0 yrs=-
0.42, 95% CI: -2.00,1.17; β, 10-19 yrs vs 0 yrs=0.02, 95% CI: -3.09,3.13; βpct, 20+ yrs vs 0 yrs=-1.37, 95% 
CI: -7.20,4.47; ptrend=0.73) or in postmenopausal women (βpct, 1-9 yrs vs 0 yrs=-0.09, 95% CI: -
1.51,1.32; βpct, 10-19 yrs vs 0 yrs=1.45, 95% CI: -1.22,4.12; βpct, 20+ yrs vs 0 yrs=1.73, 95% CI: -2.13,5.60; 
ptrend=0.22). Current rotating night shift work was associated with a non-significant increase in 
mean percent density, compared with never shift workers in premenopausal women (βpct, current vs 
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never=2.22, 95% CI: -0.97,5.41) and postmenopausal women (βpct, current vs never=1.40, 95% CI: -
4.76,7.57). 
Conclusions. While long duration of rotating night shift work has been associated with increased 
risk of breast cancer in our population, we saw no evidence that it acts through influence on 
mammographic breast density. 
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INTRODUCTION 
High mammographic breast density, or the proportion of radiologically dense breast 
tissue on a woman’s mammogram, is the strongest known risk factor for breast cancer with 
relative risks in the range of 4-6, comparing very dense breasts to very fatty breasts.[1-3] 
Mammographic density is considered to be a good intermediate endpoint for studies of 
prevention and intervention,[4] yet relatively little is understood about its causes and correlates. 
Several of the studied predictors of mammographic density are hormonally related, suggesting 
that it may be a marker of cumulative exposure to estrogen.[5-8] 
Rotating night shift work has also been shown to be a consistent risk factor for breast 
cancer.[9-13] A recent updated analysis of the Nurses’ Health Study II cohort reported the 
relative risk for invasive breast cancer to be 1.41 (95% CI:1.00,1.97  for women with 20+ years 
of rotating night shift work, compared to those with no shift work experience, over 24 years of 
follow-up (Wegrzyn dissertation paper 1, unpublished). Exposure to light at night as in night 
shift work is believed to alter circadian patterns, suppress melatonin production, and thereby 
alter hormonal profiles that play a role in cancer-related pathways. The International Agency for 
Research on Cancer (IARC) has declared shift work that involves circadian disruption to be 
“probably carcinogenic to humans” (group 2A).[14]   
Several factors have been explored for their potential to predict or affect mammographic 
density, including exogenous hormone use, circulating endogenous hormone levels, diet and 
physical activity factors. However, to our knowledge, night shift work has only been explored in 
one recent study, but may have been limited by small sample size and an exposure measure that 
may not have adequately captured the disruption of the circadian system.[15] 
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 In this analysis, we prospectively assessed the associations between rotating night shift 
work and mammographic density within a large dataset with rich information on many important 
potential confounders and predictors of mammographic density. We hypothesized that longer 
durations of night shift work would lead to increased mammographic density, thereby providing 
support for a hormonal pathway in these associations. 
METHODS 
We used subsets of women participating in the Nurses’ Health Study (NHS) and Nurses’ 
Health Study II (NHS2) for these analyses.  The NHS was established in 1976, among 121,700 
female registered nurses in the United States, ages 30-55, to assess risk factors for cardiovascular 
disease and cancer.  The NHS2 was established in 1989, enrolling 116,430 female registered 
nurses in the United States, ages 25-42, to further assess risk factors for many clinical outcomes 
in a slightly younger population.  Both studies are ongoing longitudinal studies, and participants 
report detailed information about their lifestyles, occupational and environmental exposures, 
pharmaceutical intake and medical conditions on biennial questionnaires. Subsets of both cohorts 
have also provided biological and radiological samples.  
The Institutional Review Board of Brigham & Women’s Hospital (Boston, MA) 
approved both studies, and all participants provided informed consent through the return of the 
initial questionnaire. 
Study sample 
Mammograms were collected from women within the NHS and NHS2, who were 
included in ongoing nested case-control studies of breast cancer. Participants in these substudies 
were asked to provide blood samples at various times (starting in 1989 for NHS and in 1996 for 
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NHS2) for use in studies of biomarker exposures. Every case was matched to one or two controls 
based on age, menopausal status, postmenopausal hormone use and fasting status at blood 
collection and timing of the blood collection with respect to the menstrual cycle. Mammograms 
were also collected as part of these nested case-control studies of breast cancer and were targeted 
to be screening mammograms as close as possible to the date of blood collection (before and 
after), with median time between mammogram date and blood collection date of approximately 9 
months in premenopausal women and approximately 19 months in postmenopausal women.   
Rotating night shift work information was collected from questionnaires for all 
participants in both NHS (in 1988) and NHS2 (in 1989 and then updated in 1991, 1993, 1997, 
2001, 2005 and 2007). The dataset used in these analyses was restricted to controls from the 
nested case-control studies (i.e. women free of breast cancer) with mammograms and rotating 
night shift work information. In NHS, 48 mammograms were excluded (2%) because they 
occurred prior to the shift work exposure assessment in 1988. The total sample size available for 
analyses was 4,017 (1906 premenopausal; 1860 postmenopausal; 251 missing menopausal 
status). 
Data Collection and Measurements 
Rotating night shift work assessment 
Rotating night shift work was assessed through self-reported answers to the following 
question: “What is the total number of years during which you worked rotating night shifts (at 
least 3 nights/month in addition to days/evenings that month)?”  This question was asked of all 
participants in the NHS and NHS2 studies, but at different times.  In NHS, the question was 
asked in 1988.  Since mammograms were obtained starting in 1989 with a median year of 
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collection of 1991, the NHS question can be considered to have been collected at roughly the 
same time, but reflecting cumulative past exposure.  In NHS2, the question was asked in 1989 
and then updated in 1991, 1993, 1997, 2001, 2005 and 2007 in such a way as to allow for 
determination of shift work exposure within each 2-year period. If no shift work information was 
available for a given cycle, the value from one previous cycle was used to fill in the missing 
information. To represent cumulative night shift work up to the time of the mammogram, we 
summed the durations collected through the question closest to but prior to the mammogram. 
The exposure measure of years of rotating night shift work for both cohorts was categorized as 
never, 1-9 yrs, 10-19 yrs and 20+ yrs. 
In NHS2, a current rotating night shift work exposure measure was determined from the 
information collected for the most recent 2-year period prior to the mammogram date (e.g. For a 
mammogram date in 2002, the duration of shift work was taken from the 2001 questionnaire, 
referring to the period of June 1999 – June 2001). A three category variable was used in a 
secondary analysis, with categories of current, past only and never rotating night shift work, 
adjusted for cumulative shift work duration (in months) up to the same questionnaire cycle. 
Mammographic density assessment 
Film mammograms were obtained for approximately 80% of the participants who were 
queried for mammograms.  Other work from our group has shown that the women for whom 
mammograms were obtained were similar to those for whom mammograms were not obtained 
with respect to age, BMI, parity, family history and circulating hormone levels.[16, 17] 
We used percent density, absolute dense area, and absolute non-dense area as measures 
of mammographic breast density. These were determined quantitatively using a computer-
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assisted method. For all three outcomes, measures from the cranio-caudal mammographic views 
of both breasts from each subject were averaged.  For each image, a trained reader manually set 
the appropriate gray-scale threshold level defining the edge of the breast.  The software package, 
Cumulus, then calculated the total number of pixels within the entire region of interest and 
within the regions identified as dense and non-dense. These values were used to calculate the 
percentage (dense area divided by total area) and absolute areas of the breast area that are dense 
and non-dense.[17] 
The measures of density from all the mammograms for this study were determined by 
one trained reader, whose within-person intraclass correlation coefficient has been reported as 
>0.90.[18]  The reader was blinded to the case-control status of the mammograms, and a random 
10% of mammograms were included in all batches as duplicate quality control samples.   
For NHS, mammograms were read in two batches. For NHS2, there were three batches, 
with evidence of batch-to-batch variability, or drift toward smaller dense area measurements 
over the course of the three batches. Density measurements for the latter batches were 
recalibrated to the first batch. Details of the recalibration method are described elsewhere.[16, 
19] All models in our analysis used the recalibrated NHS2 measures and were adjusted for a 
combined cohort and batch indicator variable (NHS batch 1, NHS batch 2, NHS2). 
Covariate assessment 
The following covariates were pulled from the questionnaire closest to and prior to the 
mammogram date and were considered for inclusion in all multivariable models as potential 
confounders or predictors of mammographic density: age, height, BMI, BMI at age 18, 
childhood body size (average of age 5 and 10 diagrams), adolescent body size (average of age 10 
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and 20 diagrams), age at menarche, age at first birth, parity, breastfeeding, age at menopause, 
menopausal hormone therapy (MHT) use, duration of types of MHT, first-degree family history 
of breast cancer, personal history of benign breast disease, smoking status, alcohol consumption, 
physical activity, and husband’s highest education level. 
As age at first birth and parity both contained a common reference, they were combined 
to allow for the inclusion of both in the same model ( nulliparous, age <25 yrs and 1-2 kids, age 
<25 yrs and 3+ kids, age 25-29 and 1-2 kids, age 25-29 and 3+ kids, age 30+ and 1-2 kids, and 
age 30+ and 3+ kids). See Table 2 footnotes for specific categorizations of other covariates. 
As BMI is highly correlated with mammographic density measures, we excluded 
participants with missing BMI information (<4%). Categorical variables were included in 
multivariable models with missing indicators. Missing values of continuous variables were set to 
the median and missing indicators were included in the models. 
Statistical analyses 
Linear regression was used to calculate beta estimates, or differences in the mean 
mammographic density measures, comparing each category of rotating night shift work to the no 
night shift work category. Models were run separately for each of the three outcome measures, 
and by menopausal status in the main analyses, as mammographic density distributions are very 
different among premenopausal and postmenopausal women. As residuals were skewed for the 
absolute density measures, square root transformations were applied to those outcomes and 
models were also fit using the transformed versions as the dependent variables. Generalized 
estimating equations were used to account for the correlation between matched controls, using 
the repeated statement of the SAS GENMOD procedure. 
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All models were adjusted for age at mammogram and the cohort and batch combination 
variable. Two nested multivariable models were run to highlight the change in estimates with 
adjustment for BMI and then other variables in addition to BMI. Model 2 was adjusted for age, 
cohort/batch, height, BMI at time of mammogram, BMI at age 18, and adolescent body size. 
Childhood body size and adolescent body size are highly correlated, so only adolescent body size 
was used, as it is more strongly related to the outcome. Model 3 was adjusted for the above as 
well as other predictors of mammographic density or possible confounders of the shift work and 
mammographic density association. Each covariate was added to the model individually to see if 
the exposure-outcome associations changed appreciably. All covariates were included in the final 
multivariable-adjusted model because they either substantially changed the estimate (i.e. they 
were confounders) or were associated with the outcome. See Table 2 footnotes for the complete 
list of covariates included in the multivariable models. 
Statistical significance in the main analyses was determined by Wald tests. Tests for trend 
were performed with continuous exposure measures using the midpoint of shift work duration 
categories and truncating the highest category. P-values were two-sided and values less than 0.05 
were considered statistically significant. SAS software, version 9 (SAS Institute, Cary, North 
Carolina, United States) was used for all statistical analyses. 
Secondary analyses 
Several secondary analyses were performed. For greater statistical power than our main 
analyses stratified by menopausal status, we ran models in the full NHS and NHS2 dataset of 
premenopausal and postmenopausal mammograms (N=4,017), with adjustment for menopausal 
status at time of mammogram.  
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To see if recent rotating night shift work was associated with mammographic density, we 
ran models using a shift work variable with current, past and never categories. This analysis was 
only possible in NHS2, for which we have updated shift work information. Current shift work 
was defined as reporting any shift work in the two years prior to the closest questionnaire before 
mammogram. Past shift work was defined as reporting no shift work on that same questionnaire, 
but reporting previous shift work. Never shift work was defined as not reporting any shift work 
up to the time of mammogram. The models were additionally adjusted for cumulative shift work 
duration (in months) up to the same questionnaire. Models were run stratified by menopausal 
status at time of mammogram as well as combined with adjustment for menopausal status for 
greater power. 
In addition, as other work from our group has shown that long durations of shift work 
early in adult life may confer an increased risk of breast cancer (Wegrzyn dissertation paper 1, 
unpublished) we ran models to assess association of shift work history in 1989 and 
mammographic density measures (at the start of the NHS2 cohort, when participants were ages 
25-42 in 1989). Limited sample size required the categories for shift work duration to be never, 
1-9 years, and 10+ years.  
RESULTS 
 Age-adjusted characteristics of the study population at the time of mammogram are 
presented in Table 1. Those who were in the highest category of rotating night shift work 
duration up to time of mammogram were generally older, had higher BMI as well as childhood 
and adolescent body size, were more likely to have had menarche before age 12, were more 
likely to be current smokers, and were less likely to be current users of menopausal hormone 
therapy.
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Table 1. Age-adjusted characteristics at time of mammogram, by categories of rotating night shift work duration and menopausal status at 
time of mammogram in a NHS and NHS2 pooled dataset (N premenopausal=1,906; N postmenopausal=1,860) 
 
  
Premenopausal at time of mammogram 
Years of rotating night shift work  
Postmenopausal at time of mammogram 
Years of rotating night shift work 
  None 1-9 years 10-19 years 20+ years None 1-9 years 10-19 years 20+ years 
Characteristic n=659 n=1,126 n=102 n=19 n=720 n=927 n=150 n=63 
Age 46.4  (4.3) 45.8 (4.4) 45.8 (4.4) 49.1 (3.0) 60.0 (7.3) 59.3 (7.5) 59.9 (7.9) 62.9 (7.3) 
Average breast density, % 39.9 (19.7) 39.0 (18.7) 37.4 (17.5) 31.9 (16.6) 25.2 (17.6) 24.8 (16.8) 24.2 (18.3) 23.7 (17.2) 
Average dense area, cm2 79.5 (52.7) 82.8 (51.3) 81.5 (47.6) 65.7 (35.5) 46.5 (38.6) 48.1 (38.2) 47.4 (45.1) 51.3 (49.9) 
Average nondense area, cm2 129.6 (81.0) 140.5 (82.0) 148.3 (85.9) 154.2 (65.0) 155.4 (90.8) 160.6 (94.1) 159.5 (83.6) 171.1 (89.6) 
Height, inches 64.7 (2.4) 65.0 (2.5) 64.9 (2.6) 64.0 (2.1) 64.6 (2.4) 64.6 (2.4) 64.4 (2.3) 65.3 (2.5) 
BMI, kg/m2 25.2 (4.9) 25.8 (5.6) 27.1 (6.3) 28.5 (5.7) 25.8 (4.9) 26.2 (5.3) 27.9 (6.0) 26.8 (4.8) 
BMI at age 18, kg/m2 21.2 (2.8) 21.2 (2.9) 21.8 (3.4) 21.0 (2.2) 21.1 (2.6) 21.2 (2.7) 21.6 (3.4) 21.7 (3.8) 
Childhood body size a 2.6 (1.2) 2.6 (1.2) 2.6 (1.2) 3.0 (1.4) 2.4 (1.3) 2.4 (1.3) 2.3 (1.3) 2.3 (1.3) 
Adolescent body size a 2.9 (1.1) 2.9 (1.1) 3.0 (1.1) 3.2 (0.97) 2.7 (1.1) 2.7 (1.2) 2.7 (1.1) 2.7 (1.3) 
Menarche before age 12 25 24 28 73 24 21 22 26 
Nulliparous 13 13 23 7 8 9 10 5 
Number of children b 2.5 (0.9) 2.4 (1.0) 2.4 (1.0) 2.1 (0.7) 3.3 (1.6) 3.2 (1.6) 3.2 (1.5) 3.6 (1.5) 
Age at first birth b 25.6 (3.9) 26.3 (4.3) 25.6 (4.6) 25.6 (2.4) 24.9 (3.4) 25.3 (3.4) 25.3 (3.9) 24.8 (3.0) 
Never breastfed 9 13 7 11 3 4 7 6 
Age at menopause c - - - - 48.7 (4.9) 48.4 (5.3) 48.3 (5.0) 48.9 (4.6) 
Current menopausal hormone therapy use  c - - - - 48 47 40 33 
First-degree family history of breast cancer 8 9 7 0 10 14 14 23 
History of benign breast disease 50 49 46 64 48 47 51 45 
Current smoker 7 8 9 40 8 10 13 9 
Alcohol consumption, grams/day 4.1 (7.2) 4.8 (7.8) 4.2 (8.2) 10.7 (13.5) 5.5 (9.3) 5.1 (8.5) 5.1 (9.1) 4.6 (6.9) 
Physical activity, MET-hrs/wk 16.0 (18.0) 19.3 (23.9) 22.5 (34.9) 19.1 (11.9) 18.5 (31.6) 17.6 (20.2) 21.1 (27.4) 16.1 (18.1) 
Husband’s education level college or higher d 77 80 70 79 61 62 56 49 
 
Values are means (SD) or percentages and are standardized to the age distribution of the study population.  
a Body size recalled using pictures of body outlines, numbered 1-9, leanest to fattest (NHS: 1988, NHS2: 1989) 
b Among parous women only. 
c Among postmenopausal women only. 
d Among married or widowed women only. (NHS: 1992; NHS2: 1999) 
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 Differences in average breast density measures, comparing levels of rotating night shift 
work to no shift work, were determined in three nested models for three outcomes, percent 
density, absolute dense area and absolute non-dense area (see Table 2). In the fully adjusted 
models (Model 3), women with 20+ years of shift work experience, who were premenopausal at 
time of mammogram, had 1.37 percentage points lower mean percent density (95% CI: -
7.20,4.47), 13.20 cm2 smaller mean dense area (95% CI: -26.43,0.04), and 10.13 cm2 smaller 
mean nondense area (95% CI: -34.84,14.58) than those with no shift work experience. Women 
with 20+ years of shift work duration who were postmenopausal at mammogram had 1.73 
percentage points higher mean percent density (95% CI: -2.13,5.60), 3.93 cm2 larger mean dense 
area (95% CI: -4.90,12.75), and 6.36 cm2 smaller mean nondense area (95% CI: -23.73,11.00) 
than those with no shift work experience. None of the estimates were statistically significant, and 
no significant trends across categories of shift work were evident. All models were repeated with 
versions of the exposure with 10+ years and 15+ years of shift work as the highest category, and 
no significant associations were found (data not shown). 
 Similar models were fit for square-root transformed versions of all three outcomes. On 
the square root scale in the fully adjusted models, among women premenopausal at time of 
mammogram, 20+ years of rotating night shift work was associated with 0.10 square-root 
percentage points lower mean percent density (95% CI: -0.61,0.40), 0.62 sqrt cm2 smaller mean 
dense area (95% CI: -1.38,0.14), and 0.40 sqrt cm2 smaller mean nondense area (95% CI: -
1.47,0.68), compared with no night shift work. For the same models among women 
postmenopausal at time of mammogram, 20+ years of rotating night shift work was associated 
with 0.16 square-root percentage points lower mean percent density (95% CI: -0.24,0.56), 0.21 
sqrt cm2 smaller mean dense area (95% CI: -0.36,0.77), and 0.22 sqrt cm2 smaller mean
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Table 2. Difference in average breast density measures [β (95% confidence interval)] associated with duration of rotating night shift work in 
a NHS and NHS2 pooled dataset, stratified by menopausal status (N premenopausal=1,906; N postmenopausal=1,860) 
  Premenopausal at time of mammogram Postmenopausal at time of mammogram 
  Years of rotating night shift work Years of rotating night shift work 
  None  1-9 yrs 10-19 yrs 20+ yrs   None  1-9 yrs 10-19 yrs 20+ yrs   
    β (95% CI) β (95% CI) β (95% CI) ptrend   β (95% CI) β (95% CI) β (95% CI) ptrend 
               
N 659 1,126 102 19   720 927 150 63   
Percent density (%)              
Model 1 a Ref -1.01 (-2.85,0.83) -3.20 (-6.78,0.38) -3.61 (-11.71,4.49) 0.05 Ref -0.43 (-2.07,1.21) -0.77 (-3.94,2.39) -0.22 (-4.58,4.14) 0.65 
Model 2 b Ref -0.31 (-1.90,1.29) -0.00 (-3.10,3.09) -0.91 (-6.91,5.09) 0.81 Ref 0.10 (-1.37,1.58) 1.85 (-0.98,4.67) 1.19 (-2.51,4.90) 0.21 
Model 3 c Ref -0.42 (-2.00,1.17) 0.02 (-3.09,3.13) -1.37 (-7.20,4.47) 0.73 Ref -0.09 (-1.51,1.32) 1.45 (-1.22,4.12) 1.73 (-2.13,5.60) 0.22 
Dense area (cm2)              
Model 1 Ref -1.64 (-6.21,2.93) -2.67 (-12.03,6.70) -15.41 (-30.19,-0.64) 0.19 Ref 1.55 (-1.78,4.87) 2.45 (-4.48,9.38) 2.38 (-6.54,11.29) 0.37 
Model 2 Ref -1.33 (-5.91,3.25) -0.76 (-10.08,8.55) -13.68 (-27.24,-0.12) 0.37 Ref 1.98 (-1.28,5.24) 4.07 (-2.75,10.89) 3.08 (-5.44,11.59) 0.17 
Model 3 Ref -1.38 (-5.98,3.22) -0.61 (-9.98,8.76) -13.20 (-26.43,0.04) 0.39 Ref 1.74 (-1.40,4.88) 3.56 (-2.95,10.08) 3.93 (-4.90,12.75) 0.16 
Non-dense area (cm2)              
Model 1 Ref 3.88 (-3.38,11.15) 14.75 (-1.51,31.01) 3.19 (-31.81,38.18) 0.09 Ref 6.51 (-0.99,14.00) 6.84 (-6.41,20.08) 4.70 (-16.86,26.26) 0.25 
Model 2 Ref -0.34 (-5.86,5.18) -2.16 (-15.07,10.75) -11.24 (-36.11,13.63) 0.53 Ref 3.18 (-2.80,9.16) -11.31 (-21.85,-0.77) -5.84 (-23.51,11.82) 0.11 
Model 3 Ref 0.14 (-5.36,5.65) -2.39 (-15.27,10.48) -10.13 (-34.84,14.58) 0.57 Ref 3.45 (-2.45,9.36) -10.39 (-20.79,0.01) -6.36 (-23.73,11.00) 0.13 
               
Square root percent density (%)              
Model 1 Ref -0.08 (-0.24,0.08) -0.24 (-0.56,0.08) -0.30 (-1.06,0.45) 0.09 Ref -0.03 (-0.21,0.14) -0.15 (-0.49,0.18) -0.06 (-0.53,0.41) 0.42 
Model 2 Ref -0.02 (-0.15,0.12) 0.05 (-0.22,0.32) -0.07 (-0.58,0.44) 0.95 Ref 0.03 (-0.13,0.18) 0.14 (-0.16,0.43) 0.14 (-0.16,0.43) 0.33 
Model 3 Ref -0.03 (-0.16,0.11) 0.05 (-0.22,0.32) -0.10 (-0.61,0.40) 0.98 Ref 0.01 (-0.14,0.15) 0.10 (-0.18,0.37) 0.16 (-0.24,0.56) 0.33 
Square root dense area (cm2)              
Model 1 Ref -0.09 (-0.33,0.15) -0.11 (-0.62,0.40) -0.76 (-1.63,0.10) 0.25 Ref 0.11 (-0.11,0.34) 0.02 (-0.44,0.47) 0.06 (-0.52,0.64) 0.77 
Model 2 Ref -0.06 (-0.30,0.17) 0.03 (-0.47,0.53) -0.65 (-1.41,0.12) 0.54 Ref 0.15 (-0.07,0.37) 0.17 (-0.27,0.61) 0.14 (-0.40,0.67) 0.32 
Model 3 Ref -0.07 (-0.31,0.17) 0.04 (-0.47,0.54) -0.62 (-1.38,0.14) 0.56 Ref 0.13 (-0.08,0.34) 0.13 (-0.29,0.55) 0.21 (-0.36,0.77) 0.32 
Square root non-dense area (cm2)              
Model 1 Ref 0.16 (-0.14,0.47) 0.64 (-0.01,1.28) 0.12 (-1.36,1.60) 0.08 Ref 0.26 (-0.03,0.56) 0.34 (-0.19,0.87) 0.23 (-0.19,0.87) 0.17 
Model 2 Ref -0.01 (-0.24,0.22) -0.06 (-0.56,0.44) -0.49 (-1.58,0.60) 0.57 Ref 0.13 (-0.10,0.36) -0.37 (-0.78,0.04) -0.18 (-0.89,0.53) 0.20 
Model 3 Ref 0.01 (-0.22,0.24) -0.07 (-0.57,0.43) -0.40 (-1.47,0.68) 0.64 Ref 0.15 (-0.08,0.38) -0.33 (-0.73,0.08) -0.22 (-0.92,0.49) 0.23 
 
a Model 1 is adjusted for age (continuous in months) and cohort and batch combined (NHS batch 1, NHS batch 2, NHS2) 
b Model 2 is adjusted for the above and the following: height (continuous in inches), BMI (continuous in kg/m2), BMI at age 18 (continuous in kg/m2), and adolescent body size 
(average of age 10 and age 20 diagrams). 
c Model 3 is adjusted for the above and the following: age at first birth and parity combined (nulliparous, age <25 yrs 1-2 kids, age <25 yrs 3+ kids, age 25-29 yrs 1-2 kids, age 25-
29 yrs 3+ kids, age 30+ yrs 1-2 kids, age 30+ yrs 3+ kids), first-degree family history of breast cancer (yes, no), history of benign breast disease (yes, no), alcohol consumption (0, 
0.1-5, >5 g/day). Postmenopausal models are additionally adjusted for menopausal hormone therapy use (current, past, never). 
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nondense area (95% CI: -0.92,0.49), compared with no night shift work. None of the estimates 
were statistically significant, and no significant trends across categories of shift work were 
evident. (See Table 2) 
 Secondary analyses also did not reveal any significant associations. In multivariable 
models combining premenopausal and postmenopausal mammograms, and adjusting for 
menopausal status at mammogram, rotating night shift work duration through time of 
mammogram was not associated with a significant change in mean percent density, dense area or 
non-dense area, on the original scale (βpct=-0.32, 95% CI: -3.49,2.84, ptrend=0.79; βdens=-2.86, 
95% CI: -9.87,4.16 ptrend=0.96; βnondens=-4.65, 95% CI: -18.53,9.23, ptrend=0.13) and on the 
square-root scale (βsqrtpct=-0.07, 95% CI: -0.40,0.26, ptrend=0.90; βsqrtdens=-0.22, 95% CI: -
0.67,0.24, ptrend=0.85; βsqrtnondens=-0.15, 95% CI: -0.72,0.43, ptrend=0.25). (See Table 3).  
In NHS2, current rotating night shift work, or shift work during the two years prior to the 
questionnaire before mammogram, was also not associated with any of the outcome measures, 
compared with never shift work (For percent density, premenopausal βcurrent vs never=2.22, 95% CI: 
-0.97,5.41; postmenopausal βcurrent vs never=1.40, 95% CI: -4.76,7.57) (See Table 4). This analysis 
was repeated in a dataset combining premenopausal and postmenopausal women for great 
power, and similar results were obtained (For percent density, βcurrent vs never=1.14, 95% CI: -
1.65,3.93) (See Table 5). 
 In NHS2, rotating night shift work reported at the start of the cohort (1989), when 
participants were in the age range 25-42, 10+ years of young adult shift work was also not 
associated with a significant difference in mean outcome measures, compared to those with 0 
years (For percent density, premenopausal β10+ yrs vs 0 yrs=-0.34, 95% CI: -4.30,3.61, ptrend=0.31; 
postmenopausal β10+ yrs vs 0 yrs =1.35, 95% CI: -4.83,7.53, ptrend=0.87).
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Table 3. Difference in average breast density measures [β (95% confidence interval)] associated with duration of rotating night shift work in 
a NHS and NHS2 pooled dataset, adjusted for menopausal status (N=4,017)a 
 
  Years of rotating night shift work 
  None  1-9 yrs 10-19 yrs 20+ yrs   
    β (95% CI) β (95% CI) β (95% CI) ptrend 
         
N 1467 2,187 271 92   
Percent density (%)        
Model 1 b Ref -1.03 (-2.23,0.16) -1.77 (-4.10,0.55) -1.93 (-5.74,1.87) 0.06 
Model 2 b Ref -0.38 (-1.43,0.68) 1.08 (-0.98,3.14) -0.36 (-3.48,2.77) 0.66 
Model 3 b Ref -0.46 (-1.50,0.58) 0.85 (-1.15,2.84) -0.32 (-3.49,2.84) 0.79 
Dense area (cm2)        
Model 1 Ref -0.45 (-3.18,2.27) 0.24 (-5.23,5.71) -3.79 (11.15,3.56) 0.62 
Model 2 Ref -0.04 (-2.74,2.65) 2.10 (-3.33,7.53) -2.87 (-9.83,4.09) 0.87 
Model 3 Ref -0.18 (-2.85,2.49) 1.73 (-3.62,7.07) -2.86 (-9.87,4.16) 0.96 
Non-dense area (cm2)        
Model 1 Ref 5.15 (0.17,10.12) 9.11 (-0.78,19.00) 5.53 (-11.78,22.83) 0.05 
Model 2 Ref 1.12 (-2.80,5.05) -7.98 (-15.77,-0.18) -4.29 (-18.28,9.70) 0.12 
Model 3 Ref 1.31 (-2.60,5.22) -7.65 (-15.39,0.10) -4.65 (-18.53,9.23) 0.13 
         
Square root percent density (%)        
Model 1 Ref -0.09 (-0.20,0.02) -0.19 (-0.42,0.04) -0.23 (-0.63,0.17) 0.04 
Model 2 Ref -0.02 (-0.12,0.07) 0.09 (-0.11,0.29) -0.07 (-0.40,0.25) 0.80 
Model 3 Ref -0.03 (-0.13,0.07) 0.07 (-0.12,0.26) -0.07 (-0.40,0.26) 0.90 
Square root dense area (cm2)        
Model 1 Ref -0.03 (-0.19,0.13) -0.06 (-0.39,0.27) -0.30 (-0.79,0.19) 0.34 
Model 2 Ref 0.00 (-0.15,0.16) 0.09 (-0.23,0.41) -0.22 (-0.67,0.22) 0.93 
Model 3 Ref -0.00 (-0.16,0.15) 0.07 (-0.25,0.38) -0.22 (-0.67,0.24) 0.85 
Square root non-dense area (cm2)        
Model 1 Ref 0.22 (0.02,0.42) 0.42 (0.02,0.82) 0.26 (-0.45,0.98) 0.03 
Model 2 Ref 0.06 (-0.10,0.21) -0.27 (-0.58,0.04) -0.13 (-0.71,0.44) 0.02 
Model 3 Ref 0.07 (-0.09,0.22) -0.25 (-0.56,0.05) -0.15 (-0.72,0.43) 0.25 
 
a 251 participants with missing menopausal status were included in this combined dataset with a missing indicator variable. 
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b Models 1, 2 and 3 are adjusted for the same covariates as listed in the Table 2 footnotes, with additional adjustment for menopausal status (pre/post/missing) in all models. 
  
 47 
 
Table 4. Difference in average breast density measures [β (95% confidence interval)] associated with current (in the last 2 years), past and 
never rotating night shift work in NHS2 only, stratified by menopausal status (N premenopausal=1,313; N postmenopausal=338) 
 
  Premenopausal at time of mammogram Postmenopausal at time of mammogram 
  Rotating night shift work a Rotating night shift work a 
  Never Past only Current (in last 2 yrs) Never Past only Current (in last 2 yrs) 
    β (95% CI) β (95% CI)   β (95% CI) β (95% CI) 
           
N 395 753 165 107 193 38 
Percent density (%)          
Model 1 b Ref -0.47 (-2.91,1.96) -0.78 (-2.91,1.96) Ref 1.08 (-3.58,5.74) 0.22 (-7.06,7.50) 
Model 2 b Ref -0.57 (-2.65,1.52) 2.10 (-1.17,5.37) Ref -0.39 (-4.59,3.82) 0.99 (-5.30,7.27) 
Model 3 b Ref -0.58 (-2.63,1.48) 2.22 (-0.97,5.41) Ref -0.85 (-4.88,3.17) 1.40 (-4.76,7.57) 
Dense area (cm2)         
Model 1 Ref -1.84 (-8.88,5.20) 9.86 (-2.22,21.94) Ref 1.36 (-11.08,13.81) -0.09 (-20.71,20.52) 
Model 2 Ref -1.99 (-8.96,4.98) 10.86 (-1.16,22.87) Ref -0.02 (-12.38,12.34) 1.95 (-18.10,22.00) 
Model 3 Ref -2.19 (-9.08,4.69) 10.30 (-1.54,22.15) Ref -0.23 (-11.94,11.48) 4.00 (-15.60,23.59) 
Non-dense area (cm2)         
Model 1 Ref -2.19 (-12.33,7.96) 7.86 (-9.33,25.06) Ref 1.22 (-20.37,22.80) 7.23 (-28.70,43.16) 
Model 2 Ref -2.01 (-9.72,5.71) 0.57 (-11.19,12.34) Ref 11.57 (-5.00,28.14) 5.78 (-20.77,32.33) 
Model 3 Ref -2.02 (-9.70,5.65) -0.38 (-12.09,11.32) Ref 13.19 (-4.00,30.38) 3.54 (-23.97,31.04) 
          
Square root percent density (%)          
Model 1 Ref -0.02 (-0.23,0.19) 0.08 (-0.25,0.41) Ref 0.15 (-0.26,0.57) 0.09 (-0.59,0.76) 
Model 2 Ref -0.03 (-0.20,0.15) 0.19 (-0.08,0.47) Ref 0.01 (-0.36,0.38) 0.17 (-0.41,0.74) 
Model 3 Ref -0.03 (-0.20,0.14) 0.20 (-0.07,0.47) Ref -0.03 (-0.39,0.32) 0.19 (-0.37,0.75) 
Square root dense area (cm2)         
Model 1 Ref -0.09 (-0.45,0.26) 0.49 (-0.10,1.08) Ref 0.21 (-0.47,0.88) 0.21 (-0.93,1.34) 
Model 2 Ref -0.10 (-0.45,0.25) 0.55 (-0.03,1.13) Ref 0.12 (-0.54,0.79) 0.34 (-0.75,1.42) 
Model 3 Ref -0.11 (-0.45,0.23) 0.53 (-0.04,1.10) Ref 0.09 (-0.55,0.73) 0.42 (-0.65,1.48) 
Square root non-dense area (cm2)         
Model 1 Ref -0.06 (-0.47,0.34) 0.33 (-0.34,1.01) Ref 0.01 (-0.81,0.83) 0.25 (-1.07,1.57) 
Model 2 Ref -0.05 (-0.37,0.26) 0.05 (-0.42,0.51) Ref 0.40 (-0.24,1.03) 0.17 (-0.81,1.16) 
Model 3 Ref -0.06 (-0.37,0.25) -0.00 (-0.46,0.46) Ref 0.46 (-0.19,1.11) 0.06 (-0.98,1.10) 
 
a Current rotating night shift work is defined as reporting any shift work in the 2 years prior to the closest questionnaire before mammogram. Past only is defined as reporting no 
shift work on that same questionnaire, but reporting previous shift work. Never shift workers did not report any shift work up to the time of mammogram. 
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b Models 1, 2 and 3 are adjusted for the same covariates as listed in the Table 2 footnotes, with additional adjustment for duration of shift work (months) in all models. 
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Table 5. Difference in average breast density measures [β (95% confidence interval)] associated with current (in the last 2 years), past and 
never rotating night shift work in NHS2 only, adjusted for menopausal status (N=1,732)a 
 
  Rotating night shift work b 
  Never Past only Current (in last 2 yrs) 
    β (95% CI) β (95% CI) 
      
N 533 987 212 
Percent density (%)     
Model 1 c Ref -0.39 (-2.47,1.70) 0.15 (-3.20,3.50) 
Model 2 c Ref -0.68 (-2.49,1.14) 0.94 (-1.96,3.83) 
Model 3 c Ref -0.76 (-2.55,1.03) 1.14 (-1.65,3.93) 
Dense area (cm2)     
Model 1 Ref -1.65 (-7.66,4.35) 5.63 (-4.65,15.91) 
Model 2 Ref -1.93(-7.87,4.00) 6.25 (-3.96,16.45) 
Model 3 Ref -2.56 (-8.44,3.32) 5.55 (-4.23,15.33) 
Non-dense area (cm2)     
Model 1 Ref -0.50 (-9.35,8.35) 7.72 (-7.24,22.68) 
Model 2 Ref 0.93 (-5.86,7.72) 3.20 (-7.40,13.80) 
Model 3 Ref 1.18 (-5.60,7.95) 2.25 (-8.32,12.81) 
      
Square root percent density (%)     
Model 1 Ref -0.01 (-0.19,0.17) 0.04 (-0.25,0.33) 
Model 2 Ref -0.03 (-0.19,0.12) 0.11 (-0.14,0.36) 
Model 3 Ref -0.04 (-0.19,0.11) 0.12 (-0.12,0.36) 
Square root dense area (cm2)     
Model 1 Ref -0.06 (-0.37,0.25) 0.32 (-0.19,0.84) 
Model 2 Ref -0.08 (-0.38,0.22) 0.36 (-0.14,0.87) 
Model 3 Ref -0.11 (-0.41,0.19) 0.34 (-0.15,0.82) 
Square root non-dense area (cm2)     
Model 1 Ref -0.02 (-0.37,0.33) 0.32 (-0.26,0.90) 
Model 2 Ref 0.04 (-0.23,0.31) 0.14 (-0.27,0.56) 
Model 3 Ref 0.04 (-0.23,0.31) 0.09 (-0.32,0.50) 
 
a 81 participants with missing menopausal status were included in this combined dataset with a missing indicator variable. 
b Current rotating night shift work is defined as reporting any shift work in the 2 years prior to the closest questionnaire before mammogram. Past only is defined as reporting no 
shift work on that same questionnaire, but reporting previous shift work. Never shift workers did not report any shift work up to the time of mammogram. 
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c Models 1, 2 and 3 are adjusted for the same covariates as listed in the Table 2 footnotes, with additional adjustment for duration of shift work (months) and menopausal status 
(pre/post/missing) in all models. 
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DISCUSSION 
Overall, we did not see evidence of an association between years of rotating night shift 
work and mammographic density, in premenopausal or postmenopausal women. Our results are 
consistent with the one published study of night shift work and mammographic density that 
showed no association between night shift work and mammographic density.[15]  
We saw the greatest changes in the estimates between Models 1 and 2, highlighting the 
importance of BMI as a confounder of the associations. Although we additionally adjusted for 
BMI at age 18 and adolescent body size, it is still possible that residual confounding by BMI 
may have contributed to our lack of statistically significant results. 
We also did not see significant associations between shift work and mammographic 
density with a measure of shift work close to the time of mammogram (current/past/never). 
However, the estimates were positive for percent density and may not have reached statistical 
significance due to small sample size. Current shift work was defined as any shift work reported 
in the two years prior to the most recent questionnaire before mammogram, so it may have 
reflected shift work performed as far as 4-6 years prior to the mammogram (depending on 
whether missing shift work was carried forward for one cycle), and any short-term impact to 
breast tissue may have been missed. We attempted to look at current shift work separating 1-14 
months and 15+ months in the last two years in an effort to isolate those who underwent more 
circadian disruption in the time most proximal to mammogram, but did not have a large enough 
sample size to see important differences. 
In addition, we may have been unable to capture the timing of shift work that is most 
relevant for breast tissue changes that result in elevated density. We were underpowered to look 
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at those with consistent shift work early in their adulthood (20+ years in their 20s and 30s), the 
group that saw a markedly increased risk of breast cancer in the NHS2 (Wegrzyn dissertation 
paper 1, unpublished). Further, our shift work measure itself is limited in that it uses a single 
definition of rotating night shift work (3 or more night shifts in a month with other day/evening 
shifts) and may not capture the frequency or severity of circadian disruption that could most 
affect mammographic density.  
Finally, some research shows that night shift workers are less likely to adhere to 
screening guidelines and get mammograms at the recommended times,[20] and the probability of 
getting a mammogram was inversely correlated with BMI in our data.[21] Thus, it’s possible that 
the population for which we were able to obtain mammograms is somehow less at risk for high 
mammographic density, resulting in selection bias. However, other work from our group has 
shown that the women for whom mammograms were obtained were similar to those for whom 
mammograms were not obtained with respect to age, BMI, parity, family history and circulating 
hormone levels.[16, 17] 
In conclusion, in our study population of nurses from the NHS and NHS II cohorts, we 
found no evidence for an association between rotating night shift work and mammographic 
density. It is unlikely that previously observed associations between rotating night shift work and 
breast cancer risk act through influence on mammographic breast density. 
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ABSTRACT 
Introduction. Mammographic density is a strong risk factor for breast cancer and is considered a 
good intermediate marker of breast cancer risk. Melatonin is a hormone that has anti-
carcinogenic function and is hypothesized to play a role in the reported increased risk for breast 
cancer among long-term rotating night shift workers. To our knowledge, only two studies have 
investigated the association of melatonin and mammographic density 
Methods. We conducted a cross-sectional analysis among women in the Nurses’ Health Study II 
(NHS2) who provided a first morning void urine sample and screening mammogram within a 
few years of each other. Levels of urinary 6-sulfatoxymelatonin, the main metabolite of 
melatonin, were determined by ELISA, and were standardized by creatinine concentration from 
the same sample. Percent density (%), absolute dense area (cm2) and absolute non-dense area 
(cm2) were determined from film mammograms using a computer-assisted method. 
Multivariable linear regression models were fit for each density measure separately, and were 
stratified by menopausal status a priori (Npre=480, Npost=73). Differences in mean density 
measures were reported by quartiles and tertiles of aMT6s in premenopausal women and 
postmenopausal women, respectively, adjusted for potential confounders and major predictors of 
mammographic density. 
Results. Concentrations of creatinine-adjusted aMT6s were not associated with a statistically 
significant difference in mean mammographic density, absolute dense area or nondense area, in 
premenopausal women (βpct, Q4 vs Q1= -0.52, 95% CI: -4.65,3.61; p=0.92; βdens, Q4 vs Q1= -5.27, 95% 
CI: -18.44,7.89; p=0.36; βnondens, Q4 vs Q1= -2.17, 95% CI: -18.87,14.53; p=0.56) or in 
postmenopausal women (βpct, T3 vs T1= 0.38, 95% CI: -5.49,6.26; p=0.62; βdens, T3 vs T1= 10.34, 95% 
CI: -7.33,28.01; p=0.11; βnondens, T3 vs T1= 23.76, 95% CI: -18.42,65.94; p=0.10), comparing the 
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highest quantile to the lowest quantile. Results were unchanged when restricted to those who 
were non-smokers, non-users of antidepressant medication, and those who did not work night 
shifts within 2 weeks prior to urine collection. Interaction by BMI was not significant (ppct=0.98; 
pdens=0.28; pnondens=0.86) 
Conclusions. We saw no evidence of an association between a single measure of urinary 
melatonin and mammographic density, among premenopausal or postmenopausal women. 
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INTRODUCTION 
Women with a large proportion of fibroglandular breast tissue, or high mammographic 
density, have a markedly higher risk of breast cancer, compared to women with fattier breast 
tissue. With 4-6 fold increased risk, high mammographic breast density is the strongest known 
risk factor for breast cancer.[1-3] It may be a marker of cumulative exposure to estrogen, and 
may therefore serve as a good intermediate endpoint for studies of hormonally-related 
exposures.[4-8] 
Melatonin is a hormone that serves as a marker of the circadian clocks of the body. Its 
release is stimulated by darkness and suppressed by light. Melatonin has been hypothesized to a 
play a role in cancer-related pathways through its regulation of gonadal function, modulation of 
the immune system, and through direct anti-proliferative effects on tumors.[9, 10] The reported 
association of occupational night shift work and breast cancer is thought to work through 
disruption of the circadian patterns of melatonin production and subsequent regulation of sex 
hormones.[11]  
To our knowledge, melatonin has been explored for its potential to predict or affect 
mammographic density in only two published studies. Peplonska et al reported no association 
between melatonin concentration collected in spot morning urine samples and percent density 
and absolute dense area.[12] However, they also previously reported no association with rotating 
night shift work and this measure of urinary melatonin, suggesting that the circadian disruption 
that may affect breast cancer risk was not captured by the melatonin measurement.[13] Nagata et 
al found a significantly positive association between melatonin concentration measured from 
first-void morning samples and mammographic density in premenopausal women (n=175), and 
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no association in postmenopausal women (n=123), but may have been limited by small sample 
size.[14] 
In this study, we conducted a cross-sectional analysis of urinary melatonin concentration 
from first morning void samples and mammographic density in women free of breast cancer in 
the Nurses’ Health Study II cohort. We hypothesized that higher levels of urinary melatonin 
would be associated with lower percent density and absolute dense area, and higher absolute 
non-dense area. 
METHODS 
The Nurses’ Health Study II (NHS2) provided the data for these analyses. The NHS2 
cohort was established in 1989, when 116,430 female registered nurses in the United States, ages 
25-42, returned a questionnaire reporting detailed information about their lifestyles, occupational 
and environmental exposures, medication use and medical conditions. The NHS2 is currently 
ongoing and participants update this information biennially. Follow-up in this cohort is >90%.  
The Institutional Review Board of Brigham & Women’s Hospital (Boston, MA) 
approved the NHS2, and all participants provided informed consent through the return of the 
initial questionnaire. 
Study sample 
Within the NHS2, a subcohort of women provided blood and urine samples in the period 
1996-1999. Within the group that provided these samples, a nested case-control study of breast 
cancer was formed, with one or two controls matched to cases based on age, menopausal status, 
postmenopausal hormone use, fasting status at blood collection and timing of the blood 
collection with respect to the menstrual cycle. Mammograms were collected for the case-control 
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study and were targeted to be screening mammograms close to the biomarker sample dates 
(before and after). Only urine samples and mammograms from controls (i.e. women free of 
breast cancer) were used for the present cross-sectional analyses (N=553), with median time 
between urine collection date and mammogram date of approximately 10 months in 
premenopausal women and approximately 6 months in postmenopausal women. 
Data Collection and Measurements 
Urinary melatonin metabolite measurement 
Urine samples were collected without preservatives and were shipped to our laboratory 
overnight on ice. Ninety-three percent of samples were received within 26 hours of collection. 
The stability of urinary aMT6s when processing is delayed for 24-48 hours has been previously 
shown to be reasonable.[15] Since receipt, the samples have been stored in continuously 
monitored liquid nitrogen freezers in the vapor phase (<=-130 deg C). 
The primary metabolite of melatonin, 6-sulfatoxymelatonin (aMT6s), was measured in 
the urine samples as an estimate of circulating melatonin levels. Samples were assayed in three 
batches. In 2001, the Endocrine Core Laboratory of Dr. M. Wilson (Yerkes National Primate 
Research Center, Emory University, Atlanta, Georgia) measured urinary aMT6s using a 
competitive enzyme-linked immunosorbent assay (ALPCO Diagnostics, Windham, New 
Hampshire) and urinary creatinine using a modified Jaffe method. In 2003/2005 and 2007, the 
laboratory of  Dr. Vincent Ricchiuti (now the Carroll Laboratory, Brigham and Women’s 
Hospital, Boston, Massachusetts) measured urinary aMT6s using a commercially available 
enzyme-linked immunosorbent assay (IBL International GmbH, Hamburg, Germany) and 
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urinary creatinine using the COBAS Integra 400 assay (Roche Diagnostics, Indianapolis, 
Indiana).  
Urinary aMT6s was divided by urinary creatinine to account for differences in 
concentration due to volume of the sample. aMT6s levels in this analysis are expressed as ng/mg 
creatinine. Replicate quality control samples (10% of samples) were included in each batch. As 
reported previously, within-batch coefficients of variation ranged from 2.4% to 13.9% for 
melatonin and from 1.2% to 9.2% for creatinine.[16] 
The three batches of measurements exhibited substantial drift, and were recalibrated 
using samples obtained from each of the batches (45 total, 15 from each batch that represented 
high, medium and low levels of aMT6s) and assayed at the Carroll Laboratory in 2013. Details 
of the drift recalibration are described elsewhere.[16] Briefly, linear regression was used for each 
batch, regressing the 2013 rerun values on the original laboratory values, and the estimates were 
used to predict recalibrated values for participants in that batch. 
Mammographic density assessment 
Film mammograms were obtained for approximately 80% of the participants who were 
queried for mammograms.  The mammograms were targeted to be screening mammograms, 
taken as close to the timing of the biospecimen collection as possible, as described above.  Other 
work from our group has shown that the women for whom mammograms were obtained were 
similar to those for whom mammograms were not obtained with respect to age, BMI, parity, 
family history and circulating hormone levels.[17] 
We used percent density, absolute dense area, and absolute non-dense area as measures 
of mammographic breast density. These were determined quantitatively using a computer-
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assisted method. For all three outcomes, measures from the cranio-caudal mammographic views 
of both breasts from each subject were averaged.  For each image, a trained reader manually set 
the appropriate gray-scale threshold level defining the edge of the breast.  The software package, 
Cumulus, then calculated the total number of pixels within the entire region of interest and 
within the regions identified as dense and non-dense. These values were used to calculate the 
percentage (dense area divided by total area) and absolute areas of the breast area that are dense 
and non-dense.[18] 
The measures of density from all the mammograms for this study were determined by 
one trained reader, whose within-person intraclass correlation coefficient has been reported as 
>0.90.[19]  The reader was blinded to the case-control status of the mammograms, and a random 
10% of mammograms were included in all batches as duplicate quality control samples.   
The mammograms were read in three batches, with evidence of drift toward smaller 
dense area measurements over the course of the three batches. Density measurements for the 
latter batches were recalibrated to the first batch. Details of the recalibration project are 
described elsewhere.[17, 20] Briefly, multivariable linear regression was used to estimate the 
effect of batch on density measurements and the coefficient for batch was added to the raw 
measurements in the second and third batches. These recalibrated mammographic density 
measures were used in our analyses without further adjustment for batch. 
Covariate assessment 
Covariates were pulled from the questionnaire accompanying urine collection kits or the 
main NHS2 questionnaire closest to and prior to the urine sample date. The following covariates 
were considered for inclusion in all multivariable models as potential confounders or predictors 
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of mammographic density: age, height, BMI, BMI at age 18, childhood body size (average of 
age 5 and 10 diagrams), adolescent body size (average of age 10 and 20 diagrams), age at 
menarche, age at first birth, parity, breastfeeding, age at menopause, menopausal hormone 
therapy (MHT) use, duration of types of MHT, first-degree family history of breast cancer, 
personal history of benign breast disease, smoking status and pack-years, alcohol consumption, 
physical activity, husband’s highest education level, and cumulative rotating night shift work. 
Cumulative rotating night shift work was determined by summing rotating night shift work 
history collected in 1989 (0-20+ years of 3 or more night shifts per month in months that also 
included day/evening shifts) and updated rotating night shift work duration up to the 
questionnaire prior to urine sample. Season of urine collection, first morning void sample (yes, 
no), antidepressant medication use (yes, no) and night shift work within 2 weeks prior to urine 
collection were obtained from the questionnaire that accompanied the kits and were used in 
secondary analyses.  
Categorical variables were included in multivariable models with missing indicators. 
Missing values of continuous variables were set to the median and missing indicators were 
included in the models. Less than 5% missing was noted for all variables. 
Statistical analyses 
Linear regression was used to calculate beta estimates, or differences in the mean 
mammographic density measures, comparing the highest category to the lowest category of 
creatinine-adjusted urinary aMT6s. Models were run for each of the three mammographic 
density outcomes, separately by menopausal status. Quartiles of adjusted aMT6s concentration 
were used as the exposure measure for premenopausal women (N=480) and tertiles were used for 
postmenopausal women (N=73). As residuals were skewed, square root transformations were 
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applied to all three outcomes and models were fit using the transformed versions as the 
dependent variables. Generalized estimating equations were used to account for the correlation 
between matched controls, using the repeated statement of the SAS GENMOD procedure. 
Three nested multivariable models were run to highlight the change in estimates with 
adjustment for BMI and then other variables in addition to BMI. Model 1 was adjusted for age, 
calendar season of urine collection and cumulative duration of rotating night shift work. Model 2 
was adjusted for the above as well as BMI at time of urine collection and BMI at age 18. Model 
3 was adjusted for the above as well as other predictors of mammographic density or possible 
confounders of the shift work and mammographic density association. Each covariate was added 
to the model individually to see if the exposure-outcome associations changed appreciably. All 
covariates were included in the final multivariable-adjusted model because they either changed 
the estimate (i.e. they were confounders) or were associated with the outcome. See Table 2 
footnotes for the complete list of covariates included in the multivariable models. 
Statistical significance in the analyses was determined by Wald tests. Tests for trend were 
performed with continuous exposure measures using the midpoint of the aMT6s categories. P-
values were two-sided and values less than 0.05 were considered statistically significant. SAS 
software, version 9 (SAS Institute, Cary, North Carolina, United States) was used for all 
statistical analyses. 
Secondary analyses 
Since BMI is an important determinant of mammographic density and is also highly 
correlated with urinary melatonin concentration,[21] we investigated it as a potential effect 
modifier in our analyses. We ran models stratified by BMI level (<25 kg/m2 or under/normal 
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weight, and 25+ kg/m2 or overweight/obese) in premenopausal women. Limited sample size did 
not allow for the same stratification to be performed in postmenopausal women.  
We also ran separate models restricting to non-smokers, non-users of antidepressant 
medications at time of urine collection, and those who provided first morning void samples, to 
ensure that our results were unaffected by these factors that can affect melatonin measurements. 
We also restricted to women who did not report any night shift work within the 2 weeks prior to 
urine collection in premenopausal women (none of the postmenopausal women reported such 
shift work), as night shifts have been shown to acutely reduce melatonin production.[22]  
RESULTS 
 Age-adjusted characteristics of the study population at the time of urine collection are 
presented in Table 1, stratified by menopausal status, as all analyses were conducted separately 
by menopausal status at urine collection and mammogram. Those in the highest quantiles of 
creatinine-adjusted urinary aMT6s had lower BMI and were less likely to be current smokers, 
compared to those in the lowest quantiles. They were also less likely to have worked night shifts 
in the prior two weeks before collection (among premenopausal women) and had worked fewer 
cumulative months of rotating night shifts up to that time. 
 Differences in average breast density measures, comparing the highest quantiles of 
creatinine-adjusted urinary aMT6s to the lowest, were determined in three nested models for 
three outcomes, percent density, absolute dense area and absolute non-dense area (see Table 2).  
In the fully adjusted models (Model 3), women in the highest quartile of aMT6s, who were 
premenopausal at time of mammogram, had 0.52 percentage points lower mean percent density 
(95% CI: -4.65,3.61; ptrend=0.92), 5.27 cm2 lower mean absolute dense area (95% CI: 
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Table 1. Age-adjusted characteristics at time of urine collection, by quantiles of urinary 6-sulfatoxymelatonin (aMT6S) concentration a and 
menopausal status in NHS2 (N premenopausal=480; N postmenopausal=73) 
 
  
Premenopausal b 
Quartiles of  aMT6S 
Postmenopausal  b 
Tertiles of  aMT6S 
  Q1 Q2 Q3 Q4 T1 T2 T3 
Characteristic n=120 n=120 n=120 n=120 n=24 n=25 n=24 
Average urinary aMT6S concentration 18.0 (6.3) 36.7 (4.6) 53.1 (5.6) 87.4 (22.7) 15.3 (6.6) 34.4 (6.3) 79.3 (30.8) 
Age at urine collection 44.5 (4.1) 43.6 (3.9) 43.0 (4.5) 43.7 (4.0) 48.8 (2.3) 49.3 (1.6) 48.4 (2.8) 
Age at mammogram 45.7 (4.1) 44.5 (3.9) 44.3 (4.1) 44.7 (3.8) 50.5 (3.0) 50.1 (2.8) 48.9 (2.5) 
Average breast density, % 41.5 (18.9) 42.6 (21.4) 41.9 (20.0) 46.0 (18.9) 26.1 (20.6) 28.2 (17.0) 32.2 (15.1) 
Average dense area, cm2 98.0 (55.8) 104.0 (60.3) 91.2 (46.1) 99.8 (48.1) 63.7 (44.2) 62.3 (39.2) 83.3 (43.1) 
Average nondense area, cm2 152.5 (87.3) 152.1 (84.7) 149.2 (89.5) 130.0 (73.1) 229.5 (127.1) 172.2 (78.6) 198.2 (103.0) 
Height, inches 65.1 (2.6) 65.2 (2.5) 64.8 (2.8) 64.8 (2.4) 64.2 (1.7) 65.0 (2.6) 64.7 (2.2) 
BMI, kg/m2 26.0 (5.6) 25.4 (6.1) 25.4 (5.4) 23.7 (5.1) 31.3 (9.8) 27.1 (5.7) 27.6 (6.1) 
BMI at age 18, kg/m2 21.1 (2.9) 21.0 (2.7) 21.4 (3.2) 20.5 (2.5) 25.6 (3.0) 21.8 (3.8) 20.4 (2.3) 
Childhood body size c 2.6 (1.2) 2.6 (1.1) 2.6 (1.3) 2.7 (1.1) 2.6 (1.1) 2.7 (1.3) 2.9 (1.5) 
Adolescent body size c 2.8 (1.1) 2.9 (1.0) 2.9 (1.1) 3.0 (1.1) 3.0 (1.2) 2.9 (1.1) 3.1 (1.2) 
Menarche before age 12 21 22 22 23 29 20 36 
Nulliparous 16 17 21 17 38 20 7 
Number of children d 2.3 (0.8) 2.3 (1.0) 2.4 (0.8) 2.4 (0.8) 2.3 (0.9) 2.0 (0.9) 2.0 (1.1) 
Age at first birth d 27.1 (4.5) 26.7 (4.9) 26.3 (4.3) 26.2 (4.5) 24.8 (4.3) 23.9 (5.1) 25.2 (5.1) 
Never breastfed 18 25 15 16 27 32 22 
Age at menopause e - - - - 42.4 (5.1) 43.4 (3.2) 43.3 (3.9) 
Current menopausal hormone therapy use  e - - - - 71 79 89 
First-degree family history of breast cancer 7 10 12 10 8 5 20 
History of benign breast disease 49 56 49 52 54 61 63 
Current smoker 6 6 2 2 20 8 9 
Alcohol consumption, grams/day 3.6 (5.3) 4.5 (6.8) 2.9 (5.7) 3.7 (6.3) 3.9 (5.7) 3.0 (4.7) 2.5 (4.4) 
Physical activity, MET-hrs/wk 18.2 (21.4) 21.6 (23.0) 20.6 (24.7) 20.2 (22.3) 14.4 (16.7) 14.4 (14.18) 10.0 (11.3) 
Husband’s education college or higher f 84 82 85 86 83 78 83 
Any night shifts in last 2 weeks 12 13 8 10 0 0 0 
Cumulative months of rotating night shift work g 35.8 (38.3) 32.3 (37.6) 31.7 (48.0) 28.7 (39.9) 47.3 (68.7) 49.2 (57.7) 33.3 (43.4) 
First morning urine sample 77 92 94 97 95 95 97 
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g Total 
months of 
rotating night shift work (3+ night shifts in months with day/evening shifts) through the questionnaire closest to and prior to urine collection. 
h Season of urine collection based on duration of daylight (May-July highest; Nov-Jan lowest). 
  
Antidepressant use at time of urine collection 12 11 13 11 17 17 27 
Season of urine collection h        
     February-April 35 30 27 24 34 16 23 
     May-July 25 22 17 28 33 24 23 
     August-October 23 24 26 23 5 12 27 
     November-January 16 23 30 24 29 48 28 
 
Values are means (SD) or percentages and are standardized to the age distribution of the study population, except for aMT6S, age at urine collection and age at 
mammogram.  
a Urinary 6-sulfatoxymelatonin (aMT6S) concentration is divided by urinary creatinine from the same sample to adjust for volume differences. 
b Premenopausal at time of urine collection and premenopausal at time of mammogram. Postmenopausal at time of urine collection and postmenopausal at time 
of mammogram. 
c Body size recalled using pictures of body outlines, numbered 1-9, leanest to fattest (NHS: 1988, NHS2: 1989) 
d Among parous women only. 
e Among postmenopausal women only. 
f Among married or widowed women only. (NHS: 1992; NHS2: 1999) 
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Table 2. Difference in average breast density measures [β (95% confidence interval)] associated with urinary 6-sulfatoxymelatonin (aMT6S) 
concentration a in NHS2, stratified by menopausal status (N premenopausal=480; N postmenopausal=73) 
  Premenopausal b Postmenopausal b 
  Quartiles of  aMT6S Tertiles of  aMT6S 
  Q1 Q2 Q3 Q4   T1 T2 T3   
    β (95% CI) β (95% CI) β (95% CI) ptrend   β (95% CI) β (95% CI) ptrend 
              
N 120 120 120 120  24 25 24  
Percent density (%)           
Model 1 c Ref 0.68 (-4.63,5.98) -0.59 (-5.57,4.38) 3.69 (-1.22,8.60) 0.10 Ref 0.51 (-9.00,10.03) 7.97 (-1.59,17.53) 0.05 
Model 2 d Ref -0.29 (-4.63,4.05) -1.20 (-5.44,3.04) -0.34 (-4.45,3.77) 0.93 Ref -5.15 (-13.53,3.24) 2.43 (-5.77,10.63) 0.26 
Model 3 e Ref -0.68 (-5.02,3.67) -1.50 (-5.68,2.68) -0.52 (-4.65,3.61) 0.92 Ref -3.07 (-11.47,5.33) 0.38 (-5.49,6.26) 0.62 
Dense area (cm2)           
Model 1 Ref 4.26 (-11.16,19.68) -9.68 (-22.77,3.40) -0.28 (-13.64,13.08) 0.88 Ref -1.43 (-22.83,19.97) 28.85 (4.92,52.77) 0.01 
Model 2 Ref 3.09 (-11.57,17.75) -10.24 (-23.23,2.75) -4.76 (-18.05,8.54) 0.38 Ref -11.39 (-31.95,9.17) 21.69 (-2.22,45.60) 0.02 
Model 3 Ref 1.79 (-12.43,16.01) -11.10 (-23.82,1.63) -5.27 (-18.44,7.89) 0.36 Ref -10.02 (-30.76,10.72) 10.34 (-7.33,28.01) 0.11 
Non-dense area (cm2)           
Model 1 Ref 0.82 (-22.26,23.90) -1.57 (-24.25,21.10) -20.85 (-42.24,0.54) 0.02 Ref -54.64 (-115.21,5.94) -35.74 (-95.55,24.07) 0.42 
Model 2 Ref 5.07 (-13.48,23.61) 1.24 (-17.27,19.75) -2.10 (-18.75,14.54) 0.57 Ref -16.47 (-60.18,27.24) 8.26 (-34.26,50.79) 0.46 
Model 3 Ref 5.31 (-13.11,23.73) 0.64 (-17.53,18.81) -2.17 (-18.87,14.53) 0.56 Ref -22.85 (-64.30,18.59) 23.76 (-18.42,65.94) 0.10 
            
Square root percent density 
(%)           
Model 1 Ref 0.02 (-0.44,0.48) -0.07 (-0.51,0.387) 0.32 (-0.10,0.74) 0.07 Ref 0.27 (-0.72,1.26) 1.05 (0.08,2.02) 0.02 
Model 2 Ref -0.07 (-0.44,0.30) -0.12 (-0.49,0.25) -0.03 (-0.38,0.32) 0.98 Ref -0.32 (-1.13,0.49) 0.38 (-0.40,1.17) 0.16 
Model 3 Ref -0.09 (-0.46,0.28) -0.14 (-0.50,0.22) -0.04 (-0.39,0.31) 0.99 Ref -0.16 (-0.99,0.67) 0.24 (-0.37,0.84) 0.30 
Square root dense area 
(cm2)           
Model 1 Ref 0.19 (-0.57,0.95) -0.42 (-1.09,0.25) 0.09 (-0.58,0.76) 0.82 Ref -0.00 (-1.38,1.38) 1.91 (0.52,3.31) 0.00 
Model 2 Ref 0.11 (-0.59,0.82) -0.46 (-1.11,0.20) -0.19 (-0.85,0.46) 0.48 Ref -0.65 (-1.91,0.60) 1.26 (-0.08,2.60) 0.01 
Model 3 Ref 0.06 (-0.63,0.75) -0.50 (-1.15,0.14) -0.22 (-0.87,0.43) 0.46 Ref -0.60 (-1.89,0.70) 0.82 (-0.23,1.87) 0.05 
Square root non-dense area 
(cm2)           
Model 1 Ref 0.02 (-0.88,0.92) -0.14 (-1.05,0.77) -0.83 (-1.71,0.05) 0.03 Ref -1.59 (-3.67,0.50) -1.01 (-3.01,1.00) 0.50 
Model 2 Ref 0.19 (-0.53,0.92) -0.02 (-0.76,0.71) -0.06 (-0.75,0.63) 0.68 Ref -0.33 (-1.91,1.24) 0.53 (-0.92,1.99) 0.29 
Model 3 Ref 0.21 (-0.52,0.94) -0.03 (-0.76,0.70) -0.05 (-0.75,0.64) 0.68 Ref -0.67 (-2.15,0.80) 0.78 (-0.58,2.15) 0.09 
 
a Urinary 6-sulfatoxymelatonin (aMT6S) concentration is divided by urinary creatinine from the same sample to adjust for volume differences. 
b Premenopausal at time of urine collection and premenopausal at time of mammogram. Postmenopausal at time of urine collection and postmenopausal at time of mammogram. 
c Model 1 is adjusted for age (continuous in months), cumulative shift work duration (continuous in months), season of urine collection (Feb-Apr, May-Jul, Aug-Oct, Nov-Jan) 
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d Model 2 is adjusted for the above and the following: BMI (continuous in kg/m2) and BMI at age 18 (continuous in kg/m2). 
e Model 3 is adjusted for the above and the following: age at menarche (<12, 12-13, 14+), age at first birth and parity combined (premenopausal: nulliparous, age <25 yrs 1-2 kids, 
age <25 yrs 3+ kids, age 25-29 yrs 1-2 kids, age 25-29 yrs 3+ kids, age 30+ yrs 1-2 kids, age 30+ yrs 3+ kids; postmenopausal: nulliparous, parous age <25 yrs, parous age 25-29 
yrs, parous age 30+ yrs) and history of benign breast disease (yes, no). Postmenopausal models are additionally adjusted for menopausal hormone therapy use (current, past, 
never). 
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-18.44,7.89; ptrend=0.36) and 2.17 cm2 lower mean absolute nondense area (95%CI: -18.87,14.53; 
ptrend=0.56), compared with the women in the lowest quartile of aMT6s. Women in the highest 
tertile of aMT6s, who were postmenopausal at mammogram, had 0.38 percentage points higher 
mean percent density (95% CI: -5.49,6.26; ptrend=0.62), 10.34 cm2 higher absolute dense area 
(95% CI: -7.33,28.01; ptrend=0.11), and 23.76 cm2 lower absolute nondense area (95% CI: -
18.42,65.94; ptrend=0.10) than those in the lowest tertile. None of the estimates were statistically 
significant, and no significant trends across quantiles of aMT6s were evident. 
 Square-root transformed measures were fit with the same model covariates. On the 
square root scale in the fully adjusted models, among women premenopausal at time of 
mammogram, the highest quartile of aMT6s was associated with 0.04 square-root percentage 
points lower mean percent density (95%CI: -0.39,0.31; ptrend=0.99), 0.22 sqrt cm2 smaller dense 
area (95% CI: -0.87,0.43; ptrend=0.46) and 0.05 sqrt cm2 smaller nondense area (95% CI: -0.75, 
0.64; ptrend=0.68), compared with those in the lowest quartile. Among women postmenopausal at 
time of mammogram, the highest tertile of aMT6s was associated with 0.24 square-root 
percentage points higher mean percent density (95%CI: -0.37,0.84; ptrend=0.30), 0.82 sqrt cm2 
largerer dense area (95% CI: -0.23,1.87; ptrend=0.05) and 0.78 sqrt cm2 smaller nondense area 
(95% CI: -0.58, 2.15; ptrend=0.09), compared with those in the lowest tertile. 
 Secondary analyses did not reveal any significant associations. In multivariable models 
among premenopausal women with BMI <25 kg/m2, the highest quartile of aMT6s was 
associated with 3.03 percentage points higher percent density, compared with those in the lowest 
quartile (95% CI: -2.34,8.41; ptrend=0.43). Among premenopausal women with BMI 25+ kg/m2, 
the highest quartile of aMT6s was associated with 4.14 percentage points lower percent density, 
compared with those in the lowest quartile (95% CI: -11.07,2.79; ptrend=0.55). The term for 
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interaction by BMI level was not significant for all outcomes (p values ranged 0.28-0.99). (See 
Table 3) 
 Fully adjusted models were also run separately for datasets restricted to those who were 
non-smokers at the time of urine collection (premenopausal n=462, postmenopausal n=64), those 
who provided first morning void samples (premenopausal n=438, postmenopausal n=70), those 
who were not taking antidepressant medications at time of urine collection (premenopausal 
n=424, postmenopausal n=59), and those who did not report night shift work within two weeks 
prior to urine collection (premenopausal n=444, no postmenopausal women reported such night 
shift work). All analyses yielded results similar to the main results in Table 2 (For non-smokers, 
βpct, Q4 vs Q1 premeno= -0.68, 95% CI: -4.89,3.53, p=0.98, βpct, Q4 vs Q1 postmeno= 3.94, 95% CI: -
2.53,10.41, p=0.06; For first morning void only, βpct, Q4 vs Q1 premeno= -0.55, 95% CI: -4.87,3.76, 
p=0.94, βpct, Q4 vs Q1 postmeno= 0.60, 95% CI: -6.49,7.70, p=0.52; For non-antidepressant medication 
use, βpct, Q4 vs Q1 premeno= -0.98, 95% CI: -3.28,5.24, p=0.76, βpct, Q4 vs Q1 postmeno= 1.97, 95% CI: -
5.61,9.56, p=0.33; For no night shifts in two weeks, βpct, Q4 vs Q1 premeno= -0.38, 95% CI: -
4.70,3.94, p=0.92). 
DISCUSSION 
We did not see evidence of an association between levels of creatinine-adjusted urinary 
melatonin (aMT6s) concentration and mammographic density, in our cross-sectional analysis of 
premenopausal and postmenopausal women in the NHS2. In general, the fully adjusted estimates 
were negative for percent density (the hypothesized direction) but no clear patterns or 
statistically significant trends emerged to suggest a consistent relationship.
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Table 3. Difference in average breast density measures [β (95% confidence interval)] associated with urinary 6-sulfatoxymelatonin (aMT6S) 
concentration a in NHS2, stratified by body mass index, among PREMENOPAUSAL b women only (N BMI<25 =296; N BMI 25+ =184) 
 
  BMI <25 BMI 25+   
  Quartiles of  aMT6S Quartiles of  aMT6S   
  Q1 Q2 Q3 Q4   Q1 Q2 Q3 Q4   
    β (95% CI) β (95% CI) β (95% CI) ptrend   β (95% CI) β (95% CI) β (95% CI) 
ptrend pinterac
tion 
                
N 60 75 73 88  60 45 47 32   
Percent density (%)             
Model 1 c Ref 2.70 (-3.14,8.54) 0.30 (-5.27,5.87) 2.79 (-2.90,8.47) 0.45 Ref -5.57 (-13.49,2.34) -3.76 (-10.96,3.44) -3.70 (-10.88,3.48) 0.49  
Model 2 d Ref 3.06 (-2.51,8.63) 0.53 (-4.74,5.80) 2.76 (-2.70,8.22) 0.49 Ref -5.29 (-13.02,2.44) -2.55 (-9.52,4.43) -3.41 (-10.37,3.55) 0.51  
Model 3 e Ref 3.24 (-2.36,8.84) 0.40 (-4.86,5.66) 3.03 (-2.34,8.41) 0.43 Ref -6.66 (-13.77,0.44) -4.26 (-10.99,2.46) -4.14 (-11.07,2.79) 0.55 0.98 
Dense area (cm2)             
Model 1 Ref 16.00 (-2.17,34.16) -6.86 (-22.72,9.01) 2.68 (-13.47,18.83) 0.75 Ref -14.97 (-38.67,8.73) -12.79 (-33.87,8.29) -10.40 (-33.51,12.71) 0.51  
Model 2 Ref 16.19 (-1.95,34.33) -6.69 (-22.52,9.13) 2.70 (-13.41,18.81) 0.74 Ref -14.32 (-37.65,10.63) -9.87 (-30.37,10.63) -9.87 (-32.84,13.10) 0.53  
Model 3 Ref 16.44 (-1.26,34.14) -6.41 (-22.30,9.47) 3.80 (-12.08,19.69) 0.86 Ref -18.01 (-39.69,3.67) -12.85 (-32.78,7.09) -11.46 (-35.19,12.27) 0.53 0.28 
Non-dense area 
(cm2)           
  
Model 1 Ref -4.09 (-24.53,16.36) -6.40 (-27.11,14.30) -13.26 (-33.48,6.96) 0.16 Ref 24.33 (-14.25,62.91) 19.14 (-15.28,53.57) 17.39 (-15.21,49.99) 0.54  
Model 2 Ref -6.09 (-25.42,13.24) -7.69 (-27.24,11.86) -13.57 (-33.02,5.87) 0.18 Ref 22.05 (-15.31,59.42) 13.65 (-20.93,48.22) 16.16 (-14.89,47.21) 0.54  
Model 3 Ref -6.74 (-27.20,13.72) -11.45 (-31.40,8.50) -18.12 (-37.86,1.61) 0.05 Ref 35.31 (-19.02,89.63) 46.75 (-29.40,122.9) 83.65 (8.26,159.05) 0.05 0.86 
              
Square root percent 
density (%)           
  
Model 1 Ref 0.21 (-0.24,0.66) 0.03 (-0.41,0.46) 0.22 (-0.21,0.65) 0.43 Ref -0.54 (-1.27,0.20) -0.35 (-1.04,0.34) -0.23 (-0.95,0.49) 0.75  
Model 2 Ref 0.24 (-0.19,0.66) 0.04 (-0.37,0.45) 0.22 (-0.20,0.63) 0.47 Ref -0.51 (-1.22,0.20) -0.22 (-0.89,0.45) -0.20 (-0.90,0.51) 0.79  
Model 3 Ref 0.26 (-0.16,0.69) 0.04 (-0.37,0.45) 0.24 (-0.16,0.65) 0.41 Ref -0.62 (-1.28,-0.04) -0.38 (-1.03,0.27) -0.19 (-0.87,0.48) 0.93 0.99 
Square root dense 
area (cm2)           
  
Model 1 Ref 0.74 (-0.10,1.57) -0.29 (-1.05,0.46) 0.16 (-0.60,0.92) 0.83 Ref -0.78 (-2.00,0.45) -0.59 (-1.73,0.55) -0.35 (-1.63,0.92) 0.75  
Model 2 Ref 0.75 (-0.08,1.59) -0.28 (-1.04,0.47) 0.16 (-0.60,0.92) 0.82 Ref -0.75 (-1.94,0.45) -0.41 (-1.51,0.70) -0.31 (-1.58,0.96) 0.79  
Model 3 Ref 0.77 (-0.05,1.59) -0.28 (-1.03,0.48) 0.21 (-0.54,0.96) 0.93 Ref -0.93 (-2.04,-0.18) -0.60 (-1.67,0.47) -0.32 (-1.58,0.95) 0.85 0.32 
Square root non-
dense area (cm2)           
  
Model 1 Ref -0.09 (-1.03,0.86) -0.30 (-1.28,0.67) -0.56 (-1.51,0.38) 0.19 Ref 0.80 (-0.54,2.14) 0.59 (-0.64,1.82) 0.68 (-0.46,1.81) 0.39  
Model 2 Ref -0.17 (-1.07,0.72) -0.35 (-1.27,0.57) -0.57 (-1.47,0.34) 0.21 Ref 0.74 (-0.57,2.04) 0.39 (-0.83,1.62) 0.63 (-0.45,1.71) 0.39  
Model 3 Ref -0.19 (-1.14,0.75) -0.53 (-1.46,0.40) -0.79 (-1.72,0.14) 0.05 Ref 1.33 (-0.67,3.33) 1.82 (-0.91,4.54) 3.76 (0.95,6.57) 0.27 0.41 
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a Urinary 6-sulfatoxymelatonin (aMT6S) concentration is divided by urinary creatinine from the same sample to adjust for volume differences. 
b Premenopausal at time of urine collection and premenopausal at time of mammogram. 
c Model 1 is adjusted for age (continuous in months), cumulative shift work duration (continuous in months), season of urine collection (Feb-Apr, May-Jul, Aug-Oct, Nov-Jan) 
d Model 2 is adjusted for the above and BMI at age 18 (continuous in kg/m2). 
e Model 3 is adjusted for the above and the following: age at menarche (<12, 12-13, 14+), age at first birth and parity combined (BMI <25: nulliparous, age <25 yrs 1-2 kids, age 
<25 yrs 3+ kids, age 25-29 yrs 1-2 kids, age 25-29 yrs 3+ kids, age 30+ yrs 1-2 kids, age 30+ yrs 3+ kids; BMI 25+: nulliparous, parous age <25 yrs, parous age 25+) and history 
of benign breast disease (yes, no). 
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Mammographic density is highly correlated with BMI, with heavier women having more 
fatty tissue and lower mammographic density.[23] Urinary melatonin also appears to be strongly 
and inversely related to BMI, in early life[24] as well as later adult life[21]. Although we 
attempted to remove bias due to confounding by BMI through additional adjustment for BMI at 
age 18 and childhood and adolescent body size, it is possible that our estimates were still subject 
to residual positive confounding, resulting in upwardly biased estimates (i.e. higher melatonin 
levels appearing less protective than they are). Further, higher BMI is associated with greater 
excretion of creatinine in urine, which is commonly used to adjust for urinary volume differences 
between samples. This would also serve to further depress adjusted melatonin values in those 
with higher BMI. 
In this same cohort, our measure of urinary melatonin was not associated with breast 
cancer in a recent nested case-control study, which reported a non-significant inverse association 
between the highest quartile of melatonin compared with the lowest (ORQ4 vs Q1 = 0.91, 95% CI: 
0.64,1.28, ptrend=0.38), among 600 cases and 786 controls.[16] However, long duration of 
rotating night shift work in the same cohort was associated with a significantly increased risk of 
breast cancer, when shift work measures from young adulthood (HR20+ yrs vs 0 yrs=2.15, 95%CI 
1.23-3.73) as well as updated throughout 24 years of follow-up (HR20+ yrs vs 0 yrs=1.40, 95%CI 
1.00-1.97) (Wegrzyn dissertation paper 1, unpublished). Therefore, it is possible that our single 
measure of melatonin may not have captured the circadian disruption that leads to breast tissue 
changes relevant to the development of breast cancer.  
Overall, our results are consistent with the two published papers that investigated urinary 
melatonin and mammographic density and reported no significant associations.[12, 14] 
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